NCT04417803
Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques No drug interventions other Not Available recruiting NCT03128164
A Study of HMPL-689 in Patients With Lymphomas Failed of Standard of Care or no Standard of Care Existed No drug interventions treatment 1 completed NCT02274584
CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273) No drug interventions treatment 1 / 2 unknown_status NCT00389077
Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas No drug interventions treatment 2 completed NCT00743028
Assess the Oral Bioavailability of New ABT-263 Formulations No drug interventions treatment 1 completed NCT02048488
A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 / 2 completed NCT01784185
Virtual Bronchoscopy (VB) vs. Endobronchial Ultrasound (EBUS) Guided Mediastinal Sampling No drug interventions diagnostic Not Available unknown_status NCT02661542
Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas treatment 1 / 2 completed NCT02452099
Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation. No drug interventions treatment Not Available completed NCT00788099
Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT05775406
Safety and Clinical Activity of KT-253 in Adult Patients With High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors treatment 1 recruiting NCT01237236
A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma. treatment 1 completed NCT02140736
Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology No drug interventions Not Available Not Available completed NCT02096341
A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001 treatment 1 terminated NCT01031641
Refinement of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Via Cognitive Interviewing and Usability Testing No drug interventions Not Available Not Available completed NCT01200017
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant No drug interventions Not Available Not Available no_longer_available NCT02578316
A Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients With Advanced Solid Tumors or Lymphomas, Who Are Unsuitable For, or Have Failed, Existing Therapies. treatment 1 completed NCT01836822
Bronchoscopic Sampling Techniques in Sarcoidosis No drug interventions diagnostic Not Available unknown_status NCT00023166
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas treatment 1 terminated NCT01525394
A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval basic_science 1 completed NCT02169791
Nonmyeloablative Haploidentical Transplant Followed by MLN9708 prevention 2 completed NCT00796562
Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy No drug interventions treatment 2 completed NCT00553189
Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT05773040
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas No drug interventions treatment 1 active_not_recruiting NCT00980304
R Retreatment in 1st Relapsed DLBCL No drug interventions Not Available 2 unknown_status NCT02211755
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors No drug interventions treatment 1 recruiting NCT01828008
Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas No drug interventions Not Available Not Available unknown_status NCT00222443
Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy diagnostic 1 completed NCT00396864
Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma No drug interventions treatment 1 completed NCT00968864
T-cell Depleted Alternative Donor Transplantation No drug interventions treatment 2 terminated NCT01490047
Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 withdrawn NCT00900198
Collection of Tissue Samples for Cancer Research No drug interventions Not Available Not Available recruiting NCT01194193
Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours No drug interventions treatment 1 withdrawn NCT02786485
Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT No drug interventions treatment 1 withdrawn NCT02902237
tTF-NGR Phase I Study No drug interventions treatment 1 completed NCT02740270
Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas No drug interventions treatment 1 completed NCT00006518
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer No drug interventions Not Available Not Available recruiting NCT00513318
Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies No drug interventions Not Available Not Available terminated NCT01387841
Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting No drug interventions supportive_care 2 completed NCT00725634
A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma No drug interventions treatment 1 completed NCT01512758
A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT00592163
Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 unknown_status NCT00947739
Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT00152126
Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas treatment Not Available completed NCT06148220
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors No drug interventions diagnostic Not Available recruiting NCT01359982
Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects No drug interventions treatment 1 completed NCT00167180
Post Transplant Donor Lymphocyte Infusion treatment 2 terminated NCT01851369
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas No drug interventions treatment 1 / 2 completed NCT01273155
Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction No drug interventions treatment 1 completed NCT00003243
Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer treatment 1 completed NCT03977103
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT No drug interventions treatment 2 unknown_status NCT00001503
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease No drug interventions Not Available Not Available completed NCT00857103
Effect of Interactive Tailored Assessment on Patient-provider Communication No drug interventions supportive_care Not Available completed NCT00415103
AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors No drug interventions treatment 4 completed NCT00217503
Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma treatment 2 completed NCT00586703
Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT No drug interventions treatment 1 completed NCT05156203
Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00741403
A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT06063603
Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study No drug interventions supportive_care Not Available completed NCT00935090
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer No drug interventions diagnostic Not Available recruiting NCT00363090
Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma No drug interventions treatment 1 / 2 unknown_status NCT00023790
Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin treatment 1 terminated NCT01430390
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies No drug interventions treatment 1 active_not_recruiting NCT02504190
Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM) No drug interventions Not Available Not Available completed NCT01273090
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT00948090
PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients No drug interventions treatment 2 completed NCT00005090
S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease treatment 3 terminated NCT00002590
Combination Chemotherapy in Treating Children With Lymphoma treatment 2 completed NCT03836690
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation No drug interventions treatment 1 unknown_status NCT00586690
Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT No drug interventions treatment 1 completed NCT03973164
The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma No drug interventions Not Available Not Available completed NCT00005964
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma treatment 2 completed NCT01353664
A Rollover Study for Patients Who Participated in Other Romidepsin Protocols No drug interventions treatment 2 completed NCT00014664
Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 2 unknown_status NCT03070964
A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma No drug interventions treatment 2 terminated NCT00047164
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy treatment 1 completed NCT00138164
Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 2 completed NCT00025064
Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma treatment 2 unknown_status NCT05495464
A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma No drug interventions treatment 0 recruiting NCT00006264
Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma treatment 2 completed NCT02301364
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL) No drug interventions treatment 2 completed NCT00964821
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant No drug interventions Not Available Not Available completed NCT00006721
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma treatment 3 active_not_recruiting NCT00253721
Melphalan With BBBD in Treating Patients With Brain Malignancies treatment 1 terminated NCT00301821
Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma treatment 2 completed NCT00466921
Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome No drug interventions treatment 2 completed NCT01022021
Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine No drug interventions treatment 0 completed NCT00047021
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma treatment 2 completed NCT02409121
A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers No drug interventions supportive_care Not Available completed NCT00006221
BMS-247550 in Treating Patients With Advanced Cancers treatment 1 completed NCT00003421
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease treatment 3 completed NCT00008021
Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma treatment 1 unknown_status NCT06218602
Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy. No drug interventions treatment 2 recruiting NCT00068302
Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma treatment 1 terminated NCT00589602
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases No drug interventions treatment 2 terminated NCT04657302
A Study to Evaluate Glofitamab as Single Agent Administered After Pretreatment With Obinutuzumab in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma No drug interventions treatment 1 completed NCT00002502
Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome treatment 2 completed NCT01497184
Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood No drug interventions treatment 1 completed NCT02564484
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy No drug interventions Not Available Not Available completed NCT02340884
A Pilot RCT of the PRISM Intervention for AYAs With Cancer No drug interventions health_services_research 2 completed NCT00005584
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma treatment 3 active_not_recruiting NCT01390584
Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma No drug interventions treatment 2 terminated NCT03696784
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma No drug interventions treatment 1 recruiting NCT00004084
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia No drug interventions treatment 1 / 2 completed NCT00293384
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant supportive_care Not Available completed NCT03322384
UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma No drug interventions treatment 1 / 2 completed NCT00724984
Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma No drug interventions treatment 1 / 2 completed NCT00255684
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer treatment Not Available terminated NCT00509379
Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma No drug interventions treatment 2 completed NCT00782379
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer No drug interventions treatment 2 completed NCT00005579
Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia treatment 2 completed NCT00004179
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma treatment 3 completed NCT02305979
Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies No drug interventions Not Available Not Available completed NCT01445379
Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer No drug interventions treatment 1 completed NCT00631579
Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma No drug interventions treatment 2 completed NCT03921879
Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma No drug interventions treatment 1 unknown_status NCT01412879
S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma No drug interventions treatment 2 completed NCT03489343
Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas No drug interventions treatment 1 completed NCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer No drug interventions Not Available Not Available recruiting NCT00243087
Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL) treatment 1 completed NCT00005787
Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma supportive_care 1 terminated NCT05245487
Danish Elder Lymphoma Patient Hematopoietic Investigation No drug interventions Not Available Not Available recruiting NCT00003687
Treatment for Chronic Pain in Patients With Advanced Cancer supportive_care 3 completed NCT00881387
Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment treatment 2 withdrawn NCT01210287
Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP Not Available 2 / 3 unknown_status NCT00002987
Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease treatment 3 unknown_status NCT04608487
Axi-cel in CNS Lymphoma treatment 1 active_not_recruiting NCT00365287
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer No drug interventions treatment 1 / 2 completed NCT00003887
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation No drug interventions treatment 2 completed NCT00070187
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma treatment 2 / 3 completed NCT02192333
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors No drug interventions supportive_care Not Available completed NCT02187133
Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma treatment 1 completed NCT01638533
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction treatment 1 active_not_recruiting NCT04190433
Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial supportive_care 2 withdrawn NCT03502733
Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma treatment 1 active_not_recruiting NCT00001333
Phase I Study of Intrathecal Topotecan treatment 1 completed NCT05948033
CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma No drug interventions treatment 1 / 2 recruiting NCT01310933
Ultrasonographic Differentiation Between Kikuchi's Disease and Lymphoma in Patients With Cervical Lymphadenopathy No drug interventions Not Available Not Available unknown_status NCT05332054
Long-Term Follow-up Study No drug interventions Not Available Not Available enrolling_by_invitation NCT00044954
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00005854
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT03829254
A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma treatment 1 / 2 recruiting NCT00958854
Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma treatment 2 unknown_status NCT04701554
EFFECT OF A 16-SESSION QIGONG PROGRAM ON PHYSICAL AND MENTAL HEALTH IN PATIENTS WITH LYMPHOMA: A RANDOMIZED CONTROLLED TRIAL No drug interventions treatment Not Available completed NCT00018954
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma treatment 2 completed NCT04119154
Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza) No drug interventions diagnostic Not Available completed NCT03086954
Study Evaluating the Efficacy and Safety With CAR-T Immunotherapy for CD19 Positive Lymphoma No drug interventions treatment 1 unknown_status NCT00896454
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium treatment 2 completed NCT01469754
Longitudinal Survey Analysis in Lymphoma Survivors No drug interventions Not Available Not Available completed NCT00398554
Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT00082654
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients No drug interventions Not Available Not Available completed NCT00932854
A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY) No drug interventions diagnostic Not Available unknown_status NCT00006451
Bone Marrow Transplantation in Treating Patients With Leukemia treatment 3 withdrawn NCT05834751
the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma treatment Not Available not_yet_recruiting NCT00899951
Studying Fentanyl in Patients With Cancer Not Available Not Available terminated NCT01162551
Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma treatment 2 completed NCT00473551
Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies No drug interventions treatment 1 terminated NCT00003151
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma treatment 2 completed NCT02076451
Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT02095951
Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection treatment 4 completed NCT00039351
Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma treatment 2 completed NCT02272751
Relaxation and Exercise In Lymphoma Patients No drug interventions supportive_care Not Available completed NCT00026351
Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT00416351
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment No drug interventions treatment 1 / 2 completed NCT00301951
Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer No drug interventions treatment 1 completed NCT00012051
Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma treatment 3 completed NCT06573151
Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL treatment 2 not_yet_recruiting NCT05190653
Early Integration of Palliative and Supportive Care in Cellular Therapy No drug interventions supportive_care Not Available recruiting NCT00129753
Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease treatment 2 withdrawn NCT02935153
A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT01518153
Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) treatment 2 terminated NCT03468153
Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Relapsed and Refractory Lymphoma No drug interventions treatment 1 / 2 unknown_status NCT02682953
Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers treatment 2 withdrawn NCT05898477
Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis No drug interventions Not Available Not Available recruiting NCT00416377
Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma No drug interventions treatment Not Available unknown_status NCT00546377
Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer No drug interventions treatment 1 / 2 completed NCT03052777
Using Telephone Counselling to Improve Exercise Participation in Hematologic Cancer Survivors No drug interventions supportive_care Not Available completed NCT04853277
Patient Reported Outcomes and Patient Education in Cellular Therapy Patients No drug interventions prevention Not Available completed NCT00126477
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer No drug interventions Not Available Not Available completed NCT02909777
Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma treatment 1 active_not_recruiting NCT02537977
CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy No drug interventions treatment 1 / 2 unknown_status NCT02727777
Phase II Study of TAK228 in Relapsed Lymphoma treatment 1 / 2 terminated NCT00005977
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia treatment 3 completed NCT05338047
Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant prevention 2 completed NCT00186147
Bone Marrow Grafting for Leukemia and Lymphoma No drug interventions Not Available Not Available enrolling_by_invitation NCT01714947
Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib treatment 1 completed NCT02756247
A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma treatment 1 completed NCT05011045
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies No drug interventions Not Available Not Available recruiting NCT00765245
Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00003545
506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma treatment 2 completed NCT02690545
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL No drug interventions treatment 1 / 2 recruiting NCT02053545
Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion No drug interventions treatment 1 / 2 withdrawn NCT03126045
A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hematology No drug interventions prevention Not Available completed NCT02589145
Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype treatment 1 / 2 terminated NCT00006345
Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma supportive_care 2 completed NCT00689845
Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma No drug interventions treatment Not Available unknown_status NCT00058045
Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer treatment 1 completed NCT03454945
Efficacy of Doxycycline in the Treatment of Early Stages of Mycosis Fungoides treatment 3 unknown_status NCT00004198
Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's Lymphoma treatment 2 completed NCT00109798
Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma treatment Not Available withdrawn NCT00004898
Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia treatment 1 / 2 completed NCT03262298
Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT04464798
A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas treatment 1 active_not_recruiting NCT00169598
Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study No drug interventions diagnostic Not Available unknown_status NCT01386398
Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma treatment 3 withdrawn NCT00003398
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 4 completed NCT00577798
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin No drug interventions Not Available Not Available completed NCT05779605
Telerehabilitation in Hemato-oncological Survivors No drug interventions supportive_care Not Available recruiting NCT06563505
A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma treatment 2 not_yet_recruiting NCT00003805
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count supportive_care 3 completed NCT00003605
Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma treatment 2 withdrawn NCT03312205
CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies No drug interventions treatment 1 / 2 unknown_status NCT00677105
A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. No drug interventions treatment 1 completed NCT01381705
Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma Not Available Not Available completed NCT00713505
Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction No drug interventions Not Available Not Available completed NCT00504205
MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma No drug interventions treatment Not Available terminated NCT01307605
Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular Lymphoma treatment 2 terminated NCT00005805
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer No drug interventions supportive_care 3 completed NCT00372905
Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma No drug interventions treatment 1 / 2 terminated NCT05775705
L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH No drug interventions treatment 3 not_yet_recruiting NCT00079105
A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years treatment 2 completed NCT00324597
AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 unknown_status NCT00004197
Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma treatment 2 completed NCT01390597
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms No drug interventions Not Available Not Available completed NCT01885897
IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT treatment 1 / 2 completed NCT02265497
Brazilian Network for Lymphoma Registry No drug interventions Not Available Not Available recruiting NCT01239797
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma treatment 3 completed NCT00981097
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma No drug interventions Not Available Not Available completed NCT00195897
Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX) No drug interventions Not Available Not Available terminated NCT00006383
Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma treatment 2 completed NCT01230983
Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma supportive_care 3 completed NCT00276783
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases No drug interventions treatment 2 unknown_status NCT00946283
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome No drug interventions supportive_care Not Available terminated NCT00937183
Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma No drug interventions treatment Not Available completed NCT05049083
A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects No drug interventions basic_science 1 unknown_status NCT00070083
Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma treatment 1 completed NCT00688883
Fludara (Oral) Phase II Study for Indolent Lymphoma No drug interventions treatment 2 completed NCT01216683
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma treatment 2 completed NCT03530683
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma treatment 1 terminated NCT06510361
A Phase 2 Study of Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a Complete Response With Upfront Chemoimmunotherapy treatment 2 not_yet_recruiting NCT00965861
SCRI Tissue Testing Registry No drug interventions Not Available Not Available terminated NCT00003661
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00578461
T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE No drug interventions treatment Not Available terminated NCT00188461
Dose Reduction in Thoracic CT No drug interventions diagnostic 1 completed NCT00003261
Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma treatment 2 unknown_status NCT00724061
Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL No drug interventions treatment Not Available terminated NCT00003061
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma treatment 2 completed NCT04052061
QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma treatment 1 withdrawn NCT01702961
Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease treatment Not Available completed NCT03212261
Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma No drug interventions supportive_care Not Available completed NCT00818961
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer No drug interventions treatment 2 terminated NCT03408561
Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer No drug interventions health_services_research Not Available withdrawn NCT00004061
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer supportive_care 2 completed NCT00265928
Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma treatment 2 terminated NCT00566228
Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma No drug interventions treatment 3 completed NCT00004228
Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma treatment 3 completed NCT05390528
A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma No drug interventions treatment 1 / 2 recruiting NCT00024128
Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma treatment 2 withdrawn NCT00109928
S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma treatment 2 completed NCT04154228
Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI No drug interventions diagnostic Not Available unknown_status NCT00290511
Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma treatment 2 completed NCT00040911
Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma No drug interventions supportive_care Not Available completed NCT01807611
Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy treatment 2 completed NCT04496011
Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation No drug interventions treatment Not Available unknown_status NCT00003311
Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma treatment 2 completed NCT03283111
Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma No drug interventions treatment Not Available unknown_status NCT02835911
Clinical Cohort of Lymphoma Patients in Malawi No drug interventions Not Available Not Available recruiting NCT00064311
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation supportive_care 1 / 2 completed NCT00963911
Validation of a Screening Tool in Geriatric Oncology No drug interventions screening Not Available completed NCT01561911
A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment No drug interventions Not Available 1 completed NCT05078593
A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal Antibody Injection in Patients With Solid Tumor or Lymphoma No drug interventions treatment 1 completed NCT00109993
Campath-1H + FK506 and Methylprednisolone for GVHD supportive_care 2 completed NCT00275093
Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function treatment 1 completed NCT00003993
Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma treatment 1 completed NCT00536393
Treatment of Disseminated High Grade Lymphoma No drug interventions treatment 2 / 3 completed NCT06179693
AIMN Multicenter Study: Staging of Lymphomas Using PET/CT No drug interventions Not Available Not Available completed NCT02821793
Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer No drug interventions Not Available Not Available unknown_status NCT00602693
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer No drug interventions treatment 1 completed NCT00453193
Alemtuzumab and Pentostatin In T-cell Neoplasms No drug interventions treatment 2 terminated NCT00943293
Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies treatment 1 terminated NCT00077493
BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma No drug interventions treatment 1 suspended NCT00005993
Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer treatment 1 terminated NCT01580371
Safety and Pharmacokinetic Profile of CKD-581 No drug interventions treatment 1 completed NCT03850171
Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study No drug interventions prevention Not Available terminated NCT00054171
Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT00004171
Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma treatment 2 completed NCT00006478
Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma treatment 2 terminated NCT01891578
Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation No drug interventions Not Available Not Available unknown_status NCT00889278
Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation No drug interventions Not Available Not Available completed NCT01588678
A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT00577278
A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan No drug interventions treatment 2 completed NCT05865678
Musculoskeletal Health in Adult Haematological Cancer Survivors No drug interventions Not Available Not Available recruiting NCT00003278
Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma treatment 2 completed NCT02477878
Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant treatment 1 active_not_recruiting NCT00536978
Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies No drug interventions treatment 2 completed NCT03062878
The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular Function No drug interventions Not Available Not Available completed NCT02624388
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) supportive_care 2 terminated NCT00005988
Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy treatment 1 completed NCT01742988
Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma treatment 1 completed NCT00722488
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma No drug interventions treatment 1 completed NCT00293488
SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma No drug interventions treatment 1 completed NCT00072488
Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma No drug interventions diagnostic Not Available unknown_status NCT02012088
Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb treatment 2 completed NCT00005788
Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome treatment 2 terminated NCT00513188
Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma No drug interventions treatment Not Available withdrawn NCT02106988
Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma treatment 2 recruiting NCT00003107
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors treatment 1 completed NCT00727207
Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy No drug interventions treatment 2 terminated NCT00212407
New York Blood Center National Cord Blood Program No drug interventions treatment 0 terminated NCT01132807
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma treatment 2 completed NCT04931407
A Feasibility Study in Chronically Fatigued Cancer Survivors No drug interventions other Not Available completed NCT00400907
Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9 No drug interventions Not Available Not Available unknown_status NCT00008307
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders treatment 2 unknown_status NCT01393509
The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies treatment 1 completed NCT01164709
Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer treatment 1 completed NCT01877109
Samsung Medical Center-Lymphoma Cohort Study-II No drug interventions Not Available Not Available completed NCT06510309
A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma treatment 2 not_yet_recruiting NCT00569309
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma No drug interventions treatment Not Available completed NCT00750009
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial No drug interventions other 3 completed NCT00006009
Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma treatment 1 completed NCT03344809
Enhancing Diagnosis in Chronic B-cell Lymphoproliferative Disorders Using Next-Generation Sequencing No drug interventions Not Available Not Available active_not_recruiting NCT03580109
Spa Therapy for Upper or Lower Limb Lymphoedema No drug interventions other Not Available recruiting NCT00574509
Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma No drug interventions treatment 1 completed NCT05346809
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma treatment 2 recruiting NCT00439556
Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant No drug interventions treatment 2 completed NCT00002456
Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation supportive_care 3 completed NCT00003356
Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma treatment 1 / 2 completed NCT05378256
Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors No drug interventions diagnostic Not Available recruiting NCT03698656
Effect on Patient Quality of Life of Taking Into Account the Spiritual Dimension in Nurse's Care for Haematologic Cancers. No drug interventions Not Available Not Available completed NCT03884556
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers treatment 1 completed NCT00039156
BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma treatment 2 unknown_status NCT00003056
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation supportive_care 3 terminated NCT01098656
Lenalidomide Maintenance Post-debulking in Advanced CTCL treatment 3 terminated NCT00022685
Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma treatment 3 unknown_status NCT04703985
Evaluation of the Success of Prophylactic Enteral Nutrition in Therapeutic Intensification With Autograft of Autologous Hematopoietic Cells in Hematology No drug interventions Not Available Not Available completed NCT00005985
Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma treatment 2 completed NCT00698685
Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation No drug interventions treatment 2 terminated NCT00549185
Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma No drug interventions treatment 1 completed NCT00952185
Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers No drug interventions supportive_care Not Available terminated NCT04406285
Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent. No drug interventions treatment Not Available unknown_status NCT01200485
Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 treatment 2 completed NCT00002485
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer No drug interventions Not Available Not Available completed NCT00003885
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma treatment 2 unknown_status NCT00594815
Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma No drug interventions treatment Not Available completed NCT00544115
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders No drug interventions treatment 2 active_not_recruiting NCT00691015
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant No drug interventions supportive_care 2 completed NCT00003215
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma treatment 3 completed NCT00667615
Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) No drug interventions treatment 1 / 2 completed NCT00002515
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer treatment 2 completed NCT02423915
Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention treatment 1 completed NCT00568815
Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL) No drug interventions treatment 2 completed NCT00024115
BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia No drug interventions treatment 1 withdrawn NCT02929615
Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors No drug interventions treatment 4 unknown_status NCT00688415
Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer No drug interventions other 1 completed NCT05131815
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors No drug interventions supportive_care Not Available active_not_recruiting NCT00003337
Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma No drug interventions diagnostic 3 unknown_status NCT04026737
Cardiovascular Effects of CART Cell Therapy No drug interventions Not Available Not Available completed NCT00779337
Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas No drug interventions treatment 1 completed NCT00182637
Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma treatment 2 completed NCT04186637
An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies No drug interventions treatment 1 terminated NCT00089037
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation supportive_care 1 / 2 completed NCT00511537
Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders No drug interventions Not Available Not Available completed NCT03141437
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer No drug interventions health_services_research Not Available active_not_recruiting NCT00606437
Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants No drug interventions treatment 1 completed NCT03076437
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies No drug interventions treatment 1 / 2 completed NCT00245037
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer treatment 1 / 2 completed NCT00003837
506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma treatment Not Available completed NCT04434937
Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213) treatment 2 completed NCT00048737
Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies treatment 1 / 2 completed NCT06522737
A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype treatment 3 not_yet_recruiting NCT03137537
Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy. treatment 2 terminated NCT00581737
Cognitive Functioning and Quality of Life in CNS Lymphoma No drug interventions Not Available Not Available completed NCT00003632
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma treatment 2 completed NCT00795132
Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies No drug interventions treatment 2 completed NCT05813132
BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation treatment Not Available completed NCT02704832
Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) No drug interventions other 3 unknown_status NCT00004232
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer supportive_care 1 completed NCT00041132
S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma treatment 2 completed NCT01315132
A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies No drug interventions treatment 2 completed NCT00001432
The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies No drug interventions Not Available Not Available completed NCT05371132
Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR) basic_science 1 recruiting NCT00416832
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT00006252
Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma treatment 2 completed NCT00005852
Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant treatment 2 terminated NCT02223052
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies treatment 1 completed NCT00522652
Phase I Trial of PX-478 No drug interventions treatment 1 completed NCT00377052
Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma No drug interventions treatment 2 completed NCT00001852
Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome No drug interventions Not Available Not Available completed NCT02294552
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT treatment 2 completed NCT01892852
Acupuncture for Chemotherapy-induced Peripheral Neuropathy No drug interventions treatment Not Available unknown_status NCT00691652
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma No drug interventions treatment 1 / 2 terminated NCT01608152
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors No drug interventions Not Available Not Available recruiting NCT05493800
Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT No drug interventions prevention 2 active_not_recruiting NCT00397800
Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma No drug interventions treatment 1 / 2 unknown_status NCT01541800
Circulating microRNAs as Disease Markers in Pediatric Cancers No drug interventions Not Available Not Available unknown_status NCT04039100
Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease No drug interventions supportive_care Not Available completed NCT00003600
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy supportive_care 3 completed NCT00006100
Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma treatment 1 unknown_status NCT04271800
Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma No drug interventions treatment 1 / 2 recruiting NCT00357500
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer No drug interventions treatment 2 completed NCT01027000
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma treatment 2 completed NCT00045500
UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma treatment 1 completed NCT02916459
EBUS-TBNA vs Flex 19G EBUS-TBNA No drug interventions diagnostic Not Available unknown_status NCT04466059
Better Leukemia Diagnostics Through AI (BELUGA) No drug interventions Not Available Not Available recruiting NCT05600959
Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH No drug interventions Not Available Not Available not_yet_recruiting NCT03991559
A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas treatment 1 unknown_status NCT03964259
Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia No drug interventions supportive_care 1 completed NCT00002759
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma treatment 1 completed NCT00433459
Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma No drug interventions treatment 3 completed NCT00956475
Quality of Life in Younger Leukemia and Lymphoma Survivors No drug interventions Not Available Not Available completed NCT03919175
Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma treatment 2 terminated NCT01191775
A Study of PNT2258 in Patients With Advanced Solid Tumors treatment 1 completed NCT00003575
Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma treatment 2 completed NCT00104975
Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer treatment 1 completed NCT00176475
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease treatment 1 terminated NCT00413075
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT00558675
A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy No drug interventions treatment 1 / 2 completed NCT04136275
CAR-37 T Cells In Hematologic Malignancies No drug interventions treatment 1 completed NCT05654675
Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET No drug interventions Not Available Not Available recruiting NCT01366170
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma No drug interventions Not Available Not Available completed NCT05244070
A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma treatment 1 terminated NCT02598570
Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma treatment 1 completed NCT00214370
Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma No drug interventions treatment Not Available completed NCT05120570
PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation No drug interventions supportive_care 1 / 2 recruiting NCT03476070
Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS) No drug interventions Not Available Not Available unknown_status NCT03436342
Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma No drug interventions diagnostic 0 unknown_status NCT02408042
Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) treatment 1 / 2 withdrawn NCT02905942
PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation No drug interventions treatment 4 unknown_status NCT00428142
Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT01330342
Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma No drug interventions Not Available Not Available unknown_status NCT02869542
Institut Paoli Calmettes Lymphoma Database No drug interventions Not Available Not Available recruiting NCT02733042
A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia treatment 1 / 2 completed NCT02220842
A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma treatment 1 completed NCT00309842
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases No drug interventions treatment 2 completed NCT00006342
Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor No drug interventions Not Available Not Available completed NCT00578942
Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath No drug interventions treatment 2 completed NCT00006042
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT00002742
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer supportive_care 3 completed NCT05170399
Vaccine Responses in Patients With B Cell Malignancies basic_science 4 recruiting NCT06573099
A Real-World Study on Extranodal Lymphoma No drug interventions Not Available Not Available not_yet_recruiting NCT05393999
SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations No drug interventions prevention 2 withdrawn NCT00723099
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer No drug interventions treatment 2 completed NCT00985699
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma No drug interventions Not Available Not Available completed NCT04645199
National Longitudinal Cohort of Hematological Diseases No drug interventions Not Available Not Available recruiting NCT02730299
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS treatment 3 active_not_recruiting NCT02376699
Safety Study of SEA-CD40 in Cancer Patients treatment 1 terminated NCT00661999
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer No drug interventions supportive_care 3 completed NCT01610999
Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation treatment 1 terminated NCT03016806
Umbilical Cord Blood Transplantation From Unrelated Donors treatment 1 recruiting NCT01516606
Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma treatment 2 completed NCT00004106
Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome treatment 2 terminated NCT00900406
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant No drug interventions Not Available Not Available completed NCT03638206
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies No drug interventions treatment 1 / 2 unknown_status NCT04349306
Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia treatment 4 completed NCT00882206
Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia treatment 2 terminated NCT02274506
Infusion of Allogeneic, 3rd Party CD19-specific T Cells treatment 1 withdrawn NCT00290706
A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma treatment 1 / 2 terminated NCT00110006
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma diagnostic Not Available withdrawn NCT00003849
Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease treatment 2 completed NCT02356549
African American Cancer Clinical Trial Decisions: Testing Tailored Messages No drug interventions other Not Available completed NCT00502749
Exercise Program for Adolescents and Young Adults With Cancer No drug interventions supportive_care Not Available completed NCT00110149
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 terminated NCT02710149
A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT00078949
Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma treatment 3 completed NCT03588936
Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant treatment 1 terminated NCT00082836
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma treatment Not Available completed NCT00003936
Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease treatment 2 completed NCT00001336
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients No drug interventions Not Available Not Available completed NCT00004036
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer supportive_care 1 unknown_status NCT01404936
Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease treatment 2 completed NCT00276536
Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma No drug interventions treatment 1 completed NCT01485536
A Study of the HSP90 Inhibitor AUY922 treatment 2 terminated NCT01403636
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia treatment 2 completed NCT00002936
Altretamine and Etoposide in Treating Patients With HIV-Related Cancer treatment 1 completed NCT03189836
Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma treatment 1 terminated NCT00602836
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No drug interventions treatment 2 completed NCT00709813
Study to Test a Computer-assisted Support System to Improve Patient-centered Care and Symptom Relief in Cancer Patients No drug interventions supportive_care Not Available completed NCT02694913
Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies No drug interventions Not Available Not Available completed NCT00049413
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma treatment 2 completed NCT01908413
Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma treatment 1 terminated NCT01118013
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant treatment 2 terminated NCT04074213
Clozapine and Haematologic Malignancies: Observational and Retrospective Study Using the WHO Pharmacovigilance Database Not Available Not Available unknown_status NCT00045513
Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma treatment 1 / 2 completed NCT00105313
Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia treatment 1 terminated NCT00003913
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease treatment 2 completed NCT04739813
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma treatment 1 recruiting NCT00003113
Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas treatment 2 terminated NCT06558513
To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors No drug interventions treatment 1 / 2 recruiting NCT00816413
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer No drug interventions treatment 1 / 2 withdrawn NCT01671813
Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly treatment Not Available withdrawn NCT00002718
T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia treatment 2 completed NCT05396118
Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients diagnostic 2 enrolling_by_invitation NCT00053118
Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer treatment 1 completed NCT00436618
Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment No drug interventions treatment 2 completed NCT00891618
Acupuncture for Chemo-Induced Peripheral Neuropathy No drug interventions treatment 2 completed NCT00304018
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer No drug interventions treatment 1 completed NCT01672918
Fluorodeoxyglucose Imaging Studies to Detect Lymphoma No drug interventions Not Available Not Available withdrawn NCT00530218
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant No drug interventions supportive_care 2 completed NCT00669318
Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No drug interventions treatment 2 completed NCT04187118
Quality of Life in Lymphoma Patients One Year Post-chemotherapy No drug interventions Not Available Not Available recruiting NCT00389818
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT00019019
Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas treatment 1 completed NCT00899119
Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia No drug interventions Not Available Not Available unknown_status NCT00006019
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer treatment 2 completed NCT00303719
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy No drug interventions treatment 2 terminated NCT00112619
Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors treatment 1 terminated NCT03126019
A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma treatment 2 completed NCT00376519
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases No drug interventions treatment 1 terminated NCT00544219
PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone No drug interventions treatment Not Available completed NCT00590941
Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma No drug interventions Not Available Not Available completed NCT05618041
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies No drug interventions treatment Not Available recruiting NCT04407741
Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas treatment 1 / 2 recruiting NCT00445341
Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma No drug interventions treatment 1 / 2 completed NCT00158041
Subcutaneous Amifostine Safety Study prevention 4 completed NCT02054741
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer No drug interventions supportive_care Not Available completed NCT00002941
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma treatment 2 completed NCT00003341
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy supportive_care 3 completed NCT00134017
Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer treatment 2 completed NCT00608517
Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil No drug interventions treatment Not Available terminated NCT00990717
Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies treatment 1 completed NCT01301417
Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis No drug interventions Not Available Not Available completed NCT00667017
RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma No drug interventions treatment 2 terminated NCT01276717
Study of Carfilzomib and Vorinostat for Relapsed or Refractory Lymphoma treatment 1 completed NCT03030417
Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT00516217
Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT00390117
AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma No drug interventions treatment 1 completed NCT00003217
Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia treatment 1 completed NCT00833534
Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant No drug interventions treatment 2 withdrawn NCT00005634
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy treatment 1 completed NCT03823534
Post-Op Pain Control for Prophylactic Intramedullary Nailing. treatment 3 recruiting NCT06116734
Lapelga vs Gastrofil treatment 3 not_yet_recruiting NCT01909934
Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma treatment 4 active_not_recruiting NCT00580034
Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath No drug interventions treatment 2 completed NCT01120834
Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL) treatment 1 / 2 completed NCT00352924
Agriculture Health Study No drug interventions Not Available Not Available active_not_recruiting NCT00002524
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma treatment 2 completed NCT00001424
Evaluation and Natural History of Children With Cancer and AIDS No drug interventions Not Available Not Available completed NCT00324324
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant No drug interventions supportive_care 3 terminated NCT06069024
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide No drug interventions Not Available Not Available completed NCT00674024
Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function No drug interventions treatment 1 completed NCT03586024
Pembrolizumab in Relapsed or Refractory Extranodal NK/T- Cell Lymphoma, Nasal Type and EBV-associated Diffuse Large B Cell Lymphomas treatment 1 / 2 withdrawn NCT00541424
Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma No drug interventions Not Available Not Available withdrawn NCT01421524
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma treatment 1 completed NCT01110824
Prevention of Left Ventricular Dysfunction During Chemotherapy prevention 3 completed NCT00003816
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer treatment 2 / 3 completed NCT00003716
Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy treatment 2 completed NCT00070616
Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support treatment 1 completed NCT00004916
Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma treatment 1 / 2 completed NCT03856216
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation treatment 2 recruiting NCT02961816
Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma treatment 2 withdrawn NCT00052416
Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 1 completed NCT00008216
Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer No drug interventions Not Available Not Available terminated NCT00064116
Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma treatment 3 completed NCT00928096
Breathing Adapted Radiotherapy for Mediastinal Lymphoma No drug interventions Not Available Not Available completed NCT02729896
A Study Evaluating Safety and Efficacy of Obinutuzumab, Polatuzumab Vedotin (Pola), and Atezolizumab (Atezo) in Participants With Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab, Atezo, and Pola in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) treatment 1 / 2 completed NCT00003396
Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT02961296
Helicobacter Pylori Antibiotic Susceptibility Testing of Korea No drug interventions Not Available Not Available unknown_status NCT01900496
Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma treatment 1 terminated NCT00058396
Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma treatment 1 completed NCT00723658
S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia No drug interventions treatment 2 withdrawn NCT02282358
Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma treatment 1 / 2 terminated NCT05328258
Use of GnRHa During Chemotherapy for Fertility Protection treatment 3 recruiting NCT02167958
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source treatment 1 completed NCT04604158
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients No drug interventions supportive_care Not Available completed NCT00004058
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder treatment 1 terminated NCT00004858
Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma treatment 1 unknown_status NCT00438958
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases No drug interventions treatment 3 completed NCT00002635
Aminocamptothecin in Treating Patients With T-cell Lymphoma treatment 2 completed NCT01804335
CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL) treatment 1 completed NCT03168035
Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT01916135
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative No drug interventions diagnostic 1 completed NCT00080535
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas No drug interventions treatment 2 completed NCT03524235
Haploidentical Stem Cell Transplant With Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL treatment 1 active_not_recruiting NCT01467635
EBUS-TBNA Versus EBUS-TBNB No drug interventions diagnostic Not Available withdrawn NCT00402935
Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer No drug interventions Not Available Not Available withdrawn NCT00003435
Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer treatment 1 withdrawn NCT06475235
Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL treatment 1 recruiting NCT04263935
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma No drug interventions Not Available Not Available recruiting NCT00002835
Combination Chemotherapy in Treating Patients With Lymphoma treatment 3 completed NCT01642563
Italian Platelet Technology Assessment Study No drug interventions supportive_care 3 terminated NCT00898963
Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496 No drug interventions Not Available Not Available completed NCT04236063
Rehabilitation Needs of the Malaysian Haematological Cancer Survivors No drug interventions Not Available Not Available completed NCT00003963
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation treatment 2 completed NCT05274763
Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant No drug interventions supportive_care Not Available completed NCT00589563
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer No drug interventions supportive_care 2 completed NCT04637763
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) treatment 1 recruiting NCT00074763
Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets No drug interventions treatment 3 terminated NCT06326463
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies treatment 1 recruiting NCT02091063
ACY-1215 for Relapsed/Refractory Lymphoid Malignancies treatment 1 / 2 terminated NCT05237986
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy No drug interventions Not Available Not Available suspended NCT00411086
Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma No drug interventions treatment 2 completed NCT00080886
Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma treatment 2 completed NCT02272686
Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma treatment 2 terminated NCT04472286
Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors No drug interventions Not Available Not Available completed NCT01185886
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available unknown_status NCT05631886
Combination of CAR-DC Vaccine and ICIs in Malignant Tumors treatment 1 recruiting NCT00452439
A Study of Actonel for the Prevention of Bone Loss No drug interventions treatment 3 completed NCT00003639
Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma treatment 3 unknown_status NCT02546739
Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL No drug interventions treatment 1 unknown_status NCT06347939
Mediastinal EBUS Cryobiopsy Study In Sweden No drug interventions Not Available Not Available recruiting NCT00059839
Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma treatment 3 completed NCT00004039
Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma treatment 2 withdrawn NCT00006039
Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma treatment 2 completed NCT01788839
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma No drug interventions Not Available Not Available recruiting NCT00004239
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment treatment 1 terminated NCT00007839
Beta Alethine in Treating Patients With Low-Grade Lymphoma treatment 1 / 2 unknown_status NCT00551239
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma No drug interventions treatment 3 withdrawn NCT00166439
Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma treatment 2 completed NCT00695422
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials No drug interventions Not Available Not Available completed NCT00896922
S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911 No drug interventions Not Available Not Available completed NCT00761722
Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma No drug interventions treatment 1 completed NCT05873322
Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma No drug interventions Not Available Not Available recruiting NCT00376922
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases No drug interventions supportive_care Not Available completed NCT02178722
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers treatment 1 / 2 completed NCT01649622
Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL) treatment 2 withdrawn NCT00035022
Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas treatment 1 / 2 completed NCT01527422
Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL treatment 1 / 2 completed NCT00082225
LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL) No drug interventions treatment 1 terminated NCT00006225
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer treatment 1 / 2 completed NCT01137825
Registry of Older Patients With Cancer No drug interventions Not Available Not Available recruiting NCT00217425
Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms treatment 2 completed NCT00003425
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect treatment 1 / 2 completed NCT03451825
Phase I/II Study of Avelumab in Pediatric Cancer Participants treatment 1 terminated NCT02927925
A Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type treatment 2 completed NCT01902225
Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma treatment 1 completed NCT03775525
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer treatment 1 active_not_recruiting NCT00002725
Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma treatment 2 completed NCT00080925
T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies treatment 1 completed NCT00087425
Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT06332430
Intratumoral CAN2109 in Subjects With Solid Tumors or Lymphomas No drug interventions treatment 1 not_yet_recruiting NCT00521430
Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease No drug interventions treatment Not Available completed NCT05153330
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL No drug interventions treatment 1 recruiting NCT01410630
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma Not Available Not Available completed NCT00039130
Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia treatment 2 completed NCT00387530
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer No drug interventions treatment 2 withdrawn NCT05690230
Improving Patient Experience: BMBA No drug interventions supportive_care Not Available active_not_recruiting NCT04367948
Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma No drug interventions diagnostic Not Available unknown_status NCT02856048
Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer treatment 2 / 3 unknown_status NCT00662948
ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®) No drug interventions treatment 2 completed NCT00001748
HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies No drug interventions treatment 1 completed NCT01185548
A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma treatment 1 terminated NCT00006348
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment supportive_care 3 completed NCT04423848
Home Hospital for Lymphoma No drug interventions supportive_care Not Available terminated NCT06389357
Return to School Adaptation Programme for Children With Cancer No drug interventions supportive_care Not Available enrolling_by_invitation NCT00283257
Simultaneous Care: Linking Palliation to Clinical Trials No drug interventions other Not Available completed NCT00448357
Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen No drug interventions treatment 1 / 2 completed NCT00525057
Dalteparin in Preventing DVT in Participants With Cancer No drug interventions prevention Not Available completed NCT01366157
Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma No drug interventions Not Available Not Available completed NCT00038857
Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases treatment 2 completed NCT05259657
Feasibility, Acceptability, and Preliminary Effects of Lymfit No drug interventions supportive_care Not Available completed NCT00004157
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors treatment 2 completed NCT06398457
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies treatment 0 not_yet_recruiting NCT00005626
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11) treatment 2 completed NCT03786926
Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas No drug interventions treatment 1 active_not_recruiting NCT00118326
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease treatment 1 / 2 completed NCT01300026
AMG 319 Lymphoid Malignancy FIH No drug interventions treatment 1 completed NCT00423826
Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease No drug interventions Not Available Not Available no_longer_available NCT04504526
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases No drug interventions diagnostic 0 recruiting NCT00626626
Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation No drug interventions treatment 1 / 2 terminated NCT02082626
Study of Eribulin in Children With Cancer to Determine Safety treatment 1 terminated NCT00660166
Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions No drug interventions treatment 1 completed NCT00270166
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy treatment 3 completed NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives No drug interventions Not Available Not Available recruiting NCT04510766
Tumor Molecular Profiling in Early Phase Clinical Trials No drug interventions Not Available Not Available recruiting NCT04270266
Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With Lymphoma No drug interventions supportive_care Not Available active_not_recruiting NCT00069966
Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse treatment 2 unknown_status NCT00098566
Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma No drug interventions Not Available Not Available completed NCT05080166
UPLYFT For Lymphoma Survivors No drug interventions supportive_care Not Available recruiting NCT05800366
A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma treatment 2 recruiting NCT00045266
VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma treatment 1 completed NCT00002766
Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma treatment 3 completed NCT00427765
Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma No drug interventions treatment 2 completed NCT00002765
Immunotoxin in Treating Patients With Leukemia or Lymphoma No drug interventions treatment 1 completed NCT02012465
Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients treatment 0 completed NCT02505165
Illness Management and Parental Adjustment to Cancer Treatment No drug interventions supportive_care Not Available completed NCT03936465
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer treatment 1 active_not_recruiting NCT02576665
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) treatment 1 terminated NCT02210065
Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation No drug interventions treatment 2 completed NCT01528865
Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma prevention 1 / 2 withdrawn NCT00613665
Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults No drug interventions prevention 1 completed NCT00111865
Healthy Exercise for Lymphoma Patients (HELP) No drug interventions supportive_care 3 unknown_status NCT00007865
Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma treatment 2 completed NCT03352765
A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients treatment 1 active_not_recruiting NCT00963274
Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma treatment 1 completed NCT02186574
Tenofovir to Prevent HBV Reactivation treatment 3 unknown_status NCT00136474
Amifostine for Head and Neck Irradiation in Lymphoma treatment 2 completed NCT00098774
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma treatment 2 completed NCT00608374
Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma No drug interventions treatment 3 completed NCT00005074
Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma treatment 2 completed NCT03144674
A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) treatment 2 completed NCT05506774
A Study of People With CD30 Positive Lymphoma in China No drug interventions Not Available Not Available active_not_recruiting NCT03314974
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders No drug interventions treatment 2 recruiting NCT00900120
Collecting and Storing Blood Samples From Patients With Cancer No drug interventions Not Available Not Available withdrawn NCT03371420
PET Imaging of Subjects Using 124I-PU-AD No drug interventions diagnostic 0 terminated NCT00822120
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma No drug interventions treatment 2 completed NCT04320420
Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autograft (APA²) No drug interventions supportive_care Not Available recruiting NCT00003820
Rituximab in Treating Patients With Hodgkin's Lymphoma treatment 2 completed NCT02765620
PERCIST Criteria for Response Evaluation With Solid Tumors No drug interventions Not Available Not Available unknown_status NCT00002520
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer other Not Available completed NCT03127020
Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients treatment 2 completed NCT00368082
Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) No drug interventions treatment 1 active_not_recruiting NCT03130582
High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT Not Available Not Available completed NCT00667082
NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma No drug interventions other 1 completed NCT02229682
Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy No drug interventions treatment 2 unknown_status NCT00134082
Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma treatment 1 / 2 completed NCT00014482
Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation No drug interventions Not Available Not Available completed NCT00299182
Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma No drug interventions treatment 1 / 2 completed NCT00003082
Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer No drug interventions treatment 1 completed NCT00062231
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer supportive_care Not Available terminated NCT03264131
BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma treatment 2 active_not_recruiting NCT04162431
DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (Ex Vivo Phase) No drug interventions Not Available Not Available completed NCT03862131
PROactive Evaluation of Function to Avoid CardioToxicity No drug interventions supportive_care 2 terminated NCT00003631
Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma treatment 2 completed NCT00058331
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors supportive_care 3 completed NCT00324831
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma No drug interventions treatment 3 suspended NCT00112931
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma treatment 3 completed NCT00822731
Samsung Medical Center-Lymphoma Cohort Study No drug interventions Not Available Not Available completed NCT00388531
Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma No drug interventions treatment 2 completed NCT03316573
Pembrolizumab in Neoplasms or Lymphomas treatment 2 suspended NCT02238873
Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma prevention 3 unknown_status NCT00006373
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma treatment 2 completed NCT01421173
Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies treatment 1 completed NCT02942173
CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT No drug interventions prevention 2 / 3 completed NCT03191773
A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT06236373
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia No drug interventions Not Available Not Available recruiting NCT00080873
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation No drug interventions supportive_care Not Available completed NCT00020527
Caspofungin Acetate in Treating Children With Fever and Neutropenia supportive_care Not Available completed NCT00053027
Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma treatment 2 completed NCT00784927
Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00237627
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer No drug interventions treatment 1 / 2 completed NCT00809276
Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY No drug interventions treatment 1 / 2 completed NCT03010176
Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001) treatment 1 completed NCT05239676
Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma No drug interventions treatment 0 recruiting NCT00720876
Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT03151876
Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma treatment 2 unknown_status NCT03744676
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007) treatment 2 completed NCT03205176
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas treatment 1 completed NCT00525876
Non-Myeloablative Allogeneic Stem Cell Transplantation No drug interventions treatment Not Available completed NCT00507260
Nutritional Assessment Intervention to Improve Cancer-Related Fatigue No drug interventions treatment Not Available completed NCT04465760
Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy No drug interventions supportive_care 2 terminated NCT00123760
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer No drug interventions diagnostic 2 / 3 completed NCT02465060
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) screening 2 active_not_recruiting NCT00006760
Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma treatment 2 completed NCT00001560
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers No drug interventions Not Available Not Available completed NCT00027560
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer treatment 2 completed NCT01575860
Maintenance Lenalidomide in Lymphoma treatment 1 / 2 completed NCT00512460
RTA 744 Injection in Patients With Leptomeningeal Disease No drug interventions treatment 1 terminated NCT00014560
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 1 terminated NCT00383994
Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation No drug interventions treatment 1 completed NCT00517894
Dose-Dense Therapy in Aggressive Lymphoma No drug interventions Not Available Not Available no_longer_available NCT00503594
Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine No drug interventions treatment 2 unknown_status NCT04014894
ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma No drug interventions treatment 1 unknown_status NCT00274794
VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL No drug interventions treatment Not Available completed NCT03013491
PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas treatment 1 / 2 completed NCT03330691
A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia No drug interventions treatment 1 active_not_recruiting NCT02490891
Study of the Angiogenesis by PET/CT in Patients With Lymphoma No drug interventions other 2 unknown_status NCT00028691
Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma treatment 3 unknown_status NCT00335491
Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors No drug interventions supportive_care Not Available completed NCT00392691
Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment No drug interventions treatment 1 completed NCT00070291
Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma treatment 2 terminated NCT00091091
Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma No drug interventions Not Available Not Available completed NCT00369291
CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant No drug interventions treatment 1 terminated NCT05055791
A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies No drug interventions treatment 1 / 2 not_yet_recruiting NCT00004162
Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma treatment 1 completed NCT01588262
Early Rehabilitation of Cancer Patients No drug interventions supportive_care Not Available completed NCT00003962
Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT00896662
Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 No drug interventions Not Available Not Available completed NCT01511562
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma treatment 2 active_not_recruiting NCT00003262
Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection treatment 2 unknown_status NCT03573362
Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma No drug interventions diagnostic Not Available recruiting NCT00025662
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS No drug interventions treatment 2 completed NCT00478062
Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma No drug interventions treatment 1 / 2 terminated NCT00725062
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant No drug interventions treatment 1 terminated NCT00295880
Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer No drug interventions treatment 1 / 2 terminated NCT00908180
Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma treatment 2 unknown_status NCT00002880
Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma treatment 2 completed NCT04896580
IIT2020-20-SHIRAZIP-WALK: Nature Walks No drug interventions supportive_care Not Available active_not_recruiting NCT00393380
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor No drug interventions prevention 2 terminated NCT01222780
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer treatment 1 completed NCT06060080
Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma treatment Not Available recruiting NCT02049580
Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas treatment 2 unknown_status NCT00369629
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome No drug interventions treatment 1 terminated NCT00474929
Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma No drug interventions treatment 1 / 2 completed NCT04514029
Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel prevention 0 active_not_recruiting NCT00025129
VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas treatment 1 completed NCT00506129
Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma No drug interventions treatment 2 completed NCT00003929
Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma treatment 2 withdrawn NCT00625729
Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia No drug interventions treatment 1 / 2 terminated NCT00414089
Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL No drug interventions treatment 2 withdrawn NCT00030589
Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma treatment 2 unknown_status NCT00002989
Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome treatment 3 unknown_status NCT01602289
A Study of LY2875358 in Japanese Participants With Advanced Cancer No drug interventions treatment 1 completed NCT00005589
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma treatment 3 completed NCT00265889
Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma treatment 2 completed NCT01728389
Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies. No drug interventions treatment 1 / 2 unknown_status NCT00005089
S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma treatment 2 completed NCT03684889
CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma No drug interventions treatment 1 active_not_recruiting NCT02800889
Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer No drug interventions treatment 1 withdrawn NCT00345189
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors No drug interventions treatment 1 completed NCT00003289
UCN-01 in Treating Patients With Advanced Cancer treatment 1 completed NCT00004889
Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia treatment 2 completed NCT05898789
Virtual Rehabilitation for Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT01555892
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE No drug interventions treatment 1 recruiting NCT02532192
A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma No drug interventions treatment 1 withdrawn NCT01359592
S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma No drug interventions treatment 2 completed NCT00005592
Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 2 completed NCT00058292
Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 1 completed NCT00005092
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT04746092
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19 No drug interventions Not Available Not Available unknown_status NCT02451592
Fungemia in Hematologic Malignancies No drug interventions Not Available Not Available completed NCT00967044
Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma No drug interventions treatment 1 / 2 completed NCT03235544
A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor No drug interventions treatment 2 completed NCT00935844
Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT05214144
The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients No drug interventions Not Available Not Available active_not_recruiting NCT06137144
AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies. No drug interventions treatment 1 / 2 recruiting NCT05510544
Plerixafor for Poorly Mobilized Lymphoma No drug interventions treatment 4 recruiting NCT00001444
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms treatment 1 completed NCT00458744
Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment No drug interventions treatment 1 withdrawn NCT00335140
Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma No drug interventions treatment 2 terminated NCT01947140
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies No drug interventions treatment 1 / 2 completed NCT02803840
Low-dose Radiotherapy for Diffuse Large B-cell Lymphoma No drug interventions treatment 2 unknown_status NCT04194840
Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT No drug interventions supportive_care Not Available recruiting NCT00006340
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus treatment 1 completed NCT00154440
Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation treatment 3 unknown_status NCT04873440
An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma No drug interventions treatment 1 / 2 unknown_status NCT00322140
CDDO to Treat Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT00005040
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma treatment 2 completed NCT00127140
A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030) treatment 1 completed NCT01974440
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma No drug interventions treatment 3 completed NCT05294367
Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma No drug interventions treatment 0 recruiting NCT04977167
Clinical Trial of HG146 Administered to Subjects With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 recruiting NCT00897767
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial No drug interventions Not Available Not Available completed NCT00471367
Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 No drug interventions treatment 1 terminated NCT00806767
Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer No drug interventions treatment 2 completed NCT00299767
Phase I Study of Sequential Cord Blood Transplants No drug interventions treatment 1 completed NCT03119467
Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas No drug interventions treatment 1 terminated NCT03258567
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas No drug interventions treatment 2 recruiting NCT00290667
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma treatment 2 completed NCT00005867
Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma treatment 3 completed NCT00255801
Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma treatment 2 completed NCT04497701
Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies No drug interventions prevention Not Available unknown_status NCT00005601
Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma treatment 2 completed NCT04961801
Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia No drug interventions treatment 1 / 2 withdrawn NCT00086801
Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma treatment 2 completed NCT00101101
Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma treatment 2 completed NCT00088101
STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors No drug interventions treatment 1 completed NCT00002501
Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma treatment 2 completed NCT00281801
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation No drug interventions Not Available Not Available completed NCT00134004
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer treatment 2 completed NCT00059904
Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma treatment 2 completed NCT00005804
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT03923504
Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx No drug interventions other Not Available completed NCT01794104
Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT00002504
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer treatment 2 completed NCT01729104
Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma No drug interventions treatment 1 terminated NCT00634504
Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze No drug interventions treatment 1 completed NCT00016172
ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma treatment 1 completed NCT01122472
Study of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With DLBCL and Treated With R-CHOP No drug interventions treatment 3 completed NCT01399372
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma No drug interventions treatment 2 completed NCT03647072
PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy No drug interventions treatment 3 recruiting NCT00644072
SNX-5422 to Treat Solid Tumor Cancers and Lymphomas No drug interventions treatment 1 completed NCT01538472
Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma No drug interventions treatment 1 / 2 completed NCT02924272
Ixazomib Rollover Study No drug interventions treatment 2 completed NCT03648372
A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System No drug interventions treatment 1 / 2 terminated NCT00020072
Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells No drug interventions diagnostic Not Available completed NCT00771472
Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1) No drug interventions treatment 1 completed NCT05544968
CD30biAb-AATC for CD30+ Malignancies No drug interventions treatment 1 / 2 not_yet_recruiting NCT00081068
Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia treatment 2 withdrawn NCT00238368
Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant diagnostic 2 completed NCT06371768
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors No drug interventions supportive_care Not Available not_yet_recruiting NCT04940468
High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology No drug interventions prevention Not Available recruiting NCT00088868
17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma treatment 1 completed NCT00775268
18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma No drug interventions diagnostic 1 / 2 terminated NCT02332668
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) No drug interventions treatment 1 / 2 recruiting NCT00900068
Blood Samples From Patients on a Clinical Trial to CINV During HSCT No drug interventions Not Available Not Available terminated NCT05598268
A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. No drug interventions treatment 1 / 2 recruiting NCT00031668
Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation No drug interventions treatment Not Available completed NCT04668768
HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma No drug interventions treatment 2 suspended NCT00053768
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma treatment 3 completed NCT00365768
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors No drug interventions supportive_care 2 completed NCT00006368
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer No drug interventions treatment 1 completed NCT00854568
Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL No drug interventions treatment 3 completed NCT06296368
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics No drug interventions health_services_research Not Available not_yet_recruiting NCT02652468
TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma No drug interventions treatment Not Available completed NCT06326268
Interest of Light Therapy in Hematology - The PHOTO-TREAT Study No drug interventions supportive_care Not Available recruiting NCT05010369
DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (In Vivo Phase) No drug interventions device_feasibility Not Available not_yet_recruiting NCT00004169
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease treatment 2 completed NCT00005969
Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease treatment 2 withdrawn NCT00003269
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors supportive_care 2 completed NCT00598169
Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma No drug interventions treatment 1 completed NCT02130869
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT01180569
Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma No drug interventions treatment 1 / 2 withdrawn NCT00006669
Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma treatment 2 withdrawn NCT03530969
Geriatric Communication Skills Training Program for Oncology Clinicians No drug interventions other Not Available completed NCT01231269
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma No drug interventions diagnostic Not Available active_not_recruiting NCT06193369
Digital Peer Navigation for Adolescents and Young Adults With Cancer No drug interventions supportive_care Not Available not_yet_recruiting NCT06026046
Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematology Patients No drug interventions supportive_care Not Available recruiting NCT00592046
A Phase I Trial of ZIO-101 in Hematologic Cancers No drug interventions treatment 1 completed NCT00002946
Penclomedine in Treating Patients With Solid Tumors or Lymphoma treatment 1 completed NCT00244946
Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma No drug interventions treatment 1 completed NCT00075946
Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma treatment 3 completed NCT00352846
Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss No drug interventions treatment 3 completed NCT00006246
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer treatment 1 completed NCT04544046
Supportive Oncology Care At Home RCT No drug interventions supportive_care Not Available active_not_recruiting NCT02038946
Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) No drug interventions treatment 2 completed NCT00060346
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia treatment 2 terminated NCT00036946
VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma treatment 1 completed NCT00103246
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides No drug interventions treatment 1 completed NCT05293912
SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma. No drug interventions treatment 1 recruiting NCT01141712
Autologous Transplant in HIV Patients (BMT CTN 0803) No drug interventions treatment 2 completed NCT00898612
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant No drug interventions Not Available Not Available withdrawn NCT00004112
Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma treatment 3 completed NCT00225212
Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT00516412
Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma No drug interventions treatment 2 completed NCT02849912
Signal Detection in Monoclonal and New Agents in Lymphoma No drug interventions Not Available Not Available completed NCT01327612
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) No drug interventions treatment 2 completed NCT00671112
Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma No drug interventions treatment 1 terminated NCT04541212
Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia No drug interventions Not Available Not Available recruiting NCT00301912
Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer treatment 2 withdrawn NCT05961410
Eltrombopag for Peripheral Blood Stem Cell Harvest No drug interventions treatment 2 recruiting NCT02642510
Improving Patient Education for Lymphoma and Leukemia Inpatients No drug interventions other Not Available completed NCT02958410
A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies No drug interventions treatment 1 / 2 unknown_status NCT00003110
Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 completed NCT05186610
FDG PET/CT and Directed Metabolic Core Needle Biopsy in the Management of Lymphoma No drug interventions Not Available Not Available completed NCT03674710
A Multi-center, Prospective, Single-blind, Controlled Trial Comparing Diagnostic Value of Different EUS-FNA Techniques No drug interventions diagnostic Not Available unknown_status NCT00101010
Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma treatment 2 completed NCT04983810
A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma No drug interventions treatment 1 / 2 recruiting NCT00307710
Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT01609010
A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma No drug interventions treatment 3 completed NCT04827810
A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer No drug interventions treatment 1 suspended NCT00363610
A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma No drug interventions treatment 1 terminated NCT00255710
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer supportive_care 1 completed NCT00002481
Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 2 unknown_status NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease No drug interventions Not Available Not Available recruiting NCT02743481
Early Life Exposures in Agriculture No drug interventions Not Available Not Available completed NCT02660281
URMC Related Haplo-identical Donor BMT No drug interventions treatment 1 completed NCT00369681
Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00419081
Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens No drug interventions treatment 2 terminated NCT05320081
Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma No drug interventions treatment 2 unknown_status NCT00002495
SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease treatment 3 completed NCT00816595
Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No drug interventions treatment 2 completed NCT00084695
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases treatment 2 unknown_status NCT00059995
MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma treatment 1 / 2 completed NCT00039195
Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma treatment 2 completed NCT06583395
Quest to Analyze One Thousand Humans Meditating No drug interventions Not Available Not Available enrolling_by_invitation NCT00446095
Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma No drug interventions treatment 1 / 2 completed NCT00005595
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease treatment 2 terminated NCT00003395
Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer treatment 1 completed NCT06026995
Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells No drug interventions treatment 4 recruiting NCT01213095
Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL) No drug interventions treatment 2 completed NCT00045695
Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia treatment 2 completed NCT03039114
Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102) No drug interventions treatment 1 completed NCT00417014
Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma No drug interventions treatment Not Available unknown_status NCT01427114
R-CVP for the Treatment of Non-conjunctival Ocular Adnexal MALT Lymphoma (OAML) No drug interventions treatment 2 completed NCT00004114
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer treatment 1 withdrawn NCT00521014
GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00003414
Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease treatment 3 completed NCT01841814
Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy No drug interventions diagnostic 4 withdrawn NCT03383055
CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig No drug interventions treatment 1 completed NCT00060255
High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors treatment 2 completed NCT00651755
Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients No drug interventions treatment Not Available completed NCT03932955
MC-19PD1 CAR-T in Relapsed or Refractory B Cell Lymphoma No drug interventions treatment 1 unknown_status NCT05294055
Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma No drug interventions treatment 2 recruiting NCT00513955
Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma No drug interventions treatment 2 completed NCT00006455
Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) treatment 3 completed NCT00898755
Collecting and Storing Tissue From Young Patients With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05075655
Endobronchial Diagnosis of Lymphoma No drug interventions diagnostic Not Available unknown_status NCT00003650
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma treatment 3 completed NCT00003150
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma treatment 3 completed NCT04847050
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy No drug interventions prevention 2 completed NCT05110950
Endobronchial Ultrasound Needle Aspiration With and Without Suction No drug interventions diagnostic Not Available unknown_status NCT02042950
A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma No drug interventions treatment 2 terminated NCT01078350
Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy No drug interventions Not Available Not Available completed NCT03849950
Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare) No drug interventions prevention Not Available terminated NCT05692050
Expanded Access to Epcoritamab No drug interventions Not Available Not Available no_longer_available NCT00182650
Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma treatment 1 completed NCT00583323
Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET No drug interventions diagnostic 3 completed NCT00946023
Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab No drug interventions treatment 2 terminated NCT00978523
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT03283423
Image-guided Lymphadanectomy in AMIGO No drug interventions treatment Not Available unknown_status NCT00036023
Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies treatment 2 completed NCT03852823
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours No drug interventions treatment 1 unknown_status NCT00416923
Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma No drug interventions treatment 1 completed NCT05464823
Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma No drug interventions other Not Available recruiting NCT00296023
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer No drug interventions treatment Not Available completed NCT00068523
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies treatment Not Available completed NCT00943423
PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma No drug interventions treatment 3 active_not_recruiting NCT04570423
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy No drug interventions treatment 2 recruiting NCT00897923
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma No drug interventions Not Available Not Available completed NCT01715623
Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies. No drug interventions Not Available Not Available completed NCT01744223
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant No drug interventions treatment 1 / 2 active_not_recruiting NCT01131208
Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab No drug interventions Not Available Not Available completed NCT00003408
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer treatment 2 completed NCT01700608
Prospective Observational Study on Plerixafor After Chemotherapy No drug interventions Not Available Not Available completed NCT00387608
ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer No drug interventions treatment 1 completed NCT01321008
Stage I/II Nasal NK Cell Lymphoma No drug interventions treatment 1 / 2 terminated NCT00066508
Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy treatment 2 completed NCT00006708
S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 3 terminated NCT05680038
Penpulimab in Maintenance Therapy in Lymphoma No drug interventions Not Available Not Available not_yet_recruiting NCT03336138
Application of Telemedicine to the Management of Aggressive Lymphomas No drug interventions prevention Not Available completed NCT00577538
Prevalence of Lymphoma in IBD No drug interventions Not Available Not Available completed NCT00002738
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma treatment 2 completed NCT00334438
Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma No drug interventions treatment 1 completed NCT01991938
Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma No drug interventions treatment 1 terminated NCT00967343
Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor No drug interventions prevention 2 / 3 terminated NCT00499343
G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients No drug interventions treatment 2 completed NCT02107443
Improving Communication in Older Cancer Patients and Their Caregivers No drug interventions supportive_care Not Available completed NCT00002543
Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors treatment 1 completed NCT00003143
Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation supportive_care 2 completed NCT00516503
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer No drug interventions supportive_care 3 completed NCT00075803
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) treatment 3 completed NCT05681403
Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma No drug interventions treatment Not Available not_yet_recruiting NCT00005590
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma supportive_care 3 completed NCT03731390
GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma No drug interventions treatment 1 unknown_status NCT00392990
Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma No drug interventions treatment 2 completed NCT04898790
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant No drug interventions treatment Not Available recruiting NCT00734890
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT00017290
Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma treatment 3 unknown_status NCT01504490
Phase I Study of CS-7017 and Bexarotene No drug interventions treatment 1 terminated NCT00040690
Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia treatment 2 completed NCT00036790
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer treatment 1 completed NCT01016990
Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia No drug interventions treatment 2 unknown_status NCT00520390
A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02) No drug interventions treatment 1 completed NCT00074490
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers treatment 2 terminated NCT00008164
Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia No drug interventions treatment 2 unknown_status NCT00066664
Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin No drug interventions diagnostic Not Available completed NCT05477264
Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type No drug interventions treatment 2 recruiting NCT00369564
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer No drug interventions supportive_care 3 completed NCT04088864
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies No drug interventions treatment 1 active_not_recruiting NCT00893464
A Study of IXAZOMIB in Adult Patients With Lymphoma No drug interventions treatment 1 completed NCT04014764
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy No drug interventions Not Available Not Available completed NCT00647764
Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas No drug interventions treatment 1 completed NCT01131221
S8947-9800-9911-0016A Vitamin D Insufficiency in Determining Prognosis in Patients With Newly Diagnosed Follicular Lymphoma No drug interventions Not Available Not Available completed NCT04169321
Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors No drug interventions diagnostic 1 recruiting NCT00278421
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma treatment 3 completed NCT00002621
Interferon Alfa in Treating Children With HIV-Related Cancer treatment 2 completed NCT00005021
Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma treatment 1 completed NCT05209321
Predictors of Malnutrition in Patients With Haematological Cancer No drug interventions Not Available Not Available completed NCT05891821
Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001) No drug interventions treatment 2 recruiting NCT00505921
Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma No drug interventions diagnostic 2 terminated NCT00070421
Study of @neWorld: A Virtual Community for Children With Cancer No drug interventions Not Available 1 / 2 completed NCT00002521
Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 completed NCT05969821
Clonal Hematopoiesis of Immunological Significance No drug interventions Not Available Not Available not_yet_recruiting NCT00582621
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders No drug interventions Not Available Not Available recruiting NCT00004002
PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma treatment 1 completed NCT00006102
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma treatment 2 completed NCT00425802
Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT00003402
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT00001302
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 treatment 1 completed NCT02875002
Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas No drug interventions treatment 1 withdrawn NCT02681302
Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence No drug interventions treatment 1 / 2 terminated NCT00031902
Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma treatment 1 unknown_status NCT01334502
Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma No drug interventions treatment 1 completed NCT05663502
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers No drug interventions Not Available Not Available recruiting NCT00145002
A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) treatment 3 completed NCT00438802
Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma No drug interventions treatment 1 completed NCT01563302
Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers No drug interventions treatment 1 / 2 completed NCT05702502
Assessing the Presence of CT-DNA in Lymphoma Associated HLH No drug interventions Not Available Not Available not_yet_recruiting NCT00900484
SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma No drug interventions Not Available Not Available completed NCT00531284
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma No drug interventions treatment 1 / 2 completed NCT03834584
A Study of AG-636 in the Treatment of Subjects With Advanced Lymphoma No drug interventions treatment 1 terminated NCT00666484
Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma No drug interventions treatment 2 completed NCT05922384
Safety and Efficacy Study of KL-7SHRNA Injection Solution in the Treatment of AIDS Patients With Lymphoma No drug interventions treatment Not Available recruiting NCT00461084
Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma No drug interventions Not Available Not Available completed NCT01169584
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients No drug interventions treatment 1 completed NCT00544284
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment No drug interventions treatment 1 completed NCT00869284
Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas No drug interventions treatment 2 completed NCT00003784
S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 completed NCT05081479
A Study of N-Acetylcysteine (N-AC)in People Receiving CAR T-cell Therapy for Lymphoma No drug interventions treatment 1 recruiting NCT03010579
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation No drug interventions treatment 4 unknown_status NCT00041379
Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia treatment 1 / 2 unknown_status NCT05431179
A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma No drug interventions treatment 3 withdrawn NCT00002879
Cladribine in Patients With Mantle Cell Lymphoma treatment 2 completed NCT00002779
Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma treatment 2 completed NCT00002479
Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome treatment 2 completed NCT00324779
Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT00001579
A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors treatment 1 completed NCT04081779
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study No drug interventions supportive_care Not Available enrolling_by_invitation NCT05501379
Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker No drug interventions Not Available Not Available recruiting NCT00003079
Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma treatment 1 completed NCT00281879
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer No drug interventions treatment 2 terminated NCT00006379
Non-Ablative Allo HSCT For Hematologic Malignancies or SAA treatment 2 completed NCT00233987
S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma treatment 2 completed NCT00074087
Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides treatment 2 completed NCT05064787
Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy No drug interventions supportive_care Not Available completed NCT00016887
Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma treatment 3 unknown_status NCT02733887
MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma No drug interventions diagnostic Not Available unknown_status NCT00002687
Interleukin-2 in Treating Patients With Mycosis Fungoides treatment 1 completed NCT05528887
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies No drug interventions treatment 1 recruiting NCT00003187
Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma treatment 2 / 3 completed NCT05567887
A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies No drug interventions treatment 1 active_not_recruiting NCT00863187
Assessing Antibody Responsiveness to Hepatitis B Vaccine in Aged Lymphoma Patients Undergoing Treatment With Rituximab No drug interventions Not Available Not Available unknown_status NCT00050687
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies treatment 1 / 2 terminated NCT01258933
Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy No drug interventions treatment 2 active_not_recruiting NCT00238433
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma treatment 2 completed NCT00195533
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients Not Available Not Available completed NCT02933333
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor No drug interventions treatment 4 unknown_status NCT00290433
Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma treatment 2 completed NCT01446133
Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL) No drug interventions treatment 2 active_not_recruiting NCT00433433
Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma No drug interventions treatment 3 unknown_status NCT01793233
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas No drug interventions Not Available Not Available completed NCT00013533
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies No drug interventions treatment 0 completed NCT05156554
PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation No drug interventions treatment Not Available unknown_status NCT01144754
Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT No drug interventions Not Available Not Available terminated NCT06275854
YASU Research Registry: For Young Adults With Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT05371054
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies No drug interventions treatment 1 / 2 recruiting NCT03057054
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant No drug interventions prevention 3 active_not_recruiting NCT01049854
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant No drug interventions treatment 2 completed NCT05536154
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies No drug interventions treatment Not Available recruiting NCT00493454
Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas No drug interventions treatment 2 terminated NCT00057954
Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma treatment 2 terminated NCT02065154
Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis No drug interventions prevention 2 completed NCT03733951
KN046 in Subjects With Advanced Solid Tumors and Lymphoma No drug interventions treatment 1 completed NCT00001251
Phase I Study of Intrathecal Mafosfamide treatment 1 completed NCT05135351
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation No drug interventions supportive_care Not Available recruiting NCT05357651
A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001） No drug interventions treatment 1 recruiting NCT00003451
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer treatment 1 completed NCT04511351
Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma No drug interventions treatment Not Available unknown_status NCT00611351
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer No drug interventions treatment 2 completed NCT01625351
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT00053053
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer No drug interventions supportive_care 3 completed NCT02369653
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase No drug interventions prevention 3 completed NCT00920153
Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma No drug interventions treatment 3 terminated NCT04716153
Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemotherapy for Haematological Cancer No drug interventions prevention Not Available recruiting NCT00430053
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma No drug interventions Not Available Not Available completed NCT00002553
Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer treatment 2 completed NCT00488553
Molecular Epidemiology of Lymphoma Patients No drug interventions Not Available Not Available withdrawn NCT00055653
Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders treatment 2 completed NCT05921253
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy No drug interventions other Not Available recruiting NCT00003077
Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss No drug interventions supportive_care 1 / 2 completed NCT04062877
Clinical Application of Liquid Biopsy for Precise Diagnosis and Prognosis in Lymphoma No drug interventions Not Available Not Available completed NCT06335277
Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology No drug interventions Not Available Not Available recruiting NCT00893477
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma No drug interventions treatment 2 unknown_status NCT04593277
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study No drug interventions supportive_care Not Available recruiting NCT01240577
An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT05403177
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) No drug interventions Not Available Not Available recruiting NCT03200977
Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab No drug interventions Not Available Not Available unknown_status NCT03995147
Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma No drug interventions treatment 2 recruiting NCT02918747
PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage No drug interventions treatment 2 unknown_status NCT00070447
Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma treatment 2 completed NCT00006747
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma treatment 2 completed NCT05907447
A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types No drug interventions Not Available Not Available not_yet_recruiting NCT02974647
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma No drug interventions treatment 2 recruiting NCT02656147
Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL No drug interventions treatment 1 unknown_status NCT00720447
Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma No drug interventions treatment 2 unknown_status NCT02601547
PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma No drug interventions Not Available Not Available completed NCT06487247
HEME Home Transfusion Program No drug interventions supportive_care Not Available not_yet_recruiting NCT02954445
A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT00003245
Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma treatment 2 completed NCT01350245
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor No drug interventions treatment 2 completed NCT00060645
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED) treatment 1 completed NCT00004145
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00782145
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families No drug interventions supportive_care 3 completed NCT00619645
Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers No drug interventions treatment 2 completed NCT01720745
Comparison of "Wet Suction" Technique to Contemporary "Dry Suction" Technique Using a 22 Gauge Needle for EUS FNA No drug interventions Not Available Not Available terminated NCT00428545
Bevacizumab and Bortezomib in Patients With Advanced Malignancy No drug interventions treatment 1 completed NCT00002745
Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma treatment 2 completed NCT04069845
A Registry Study in Lymphoma Patients Treated With Liposomal Doxorubicin No drug interventions Not Available Not Available unknown_status NCT05565898
PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow Infiltration for Initial Staging of Lymphoma No drug interventions Not Available Not Available not_yet_recruiting NCT00117598
Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) treatment 3 completed NCT03141398
Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group No drug interventions Not Available Not Available withdrawn NCT04300998
Study of CAR-T Therapy in Older Patients No drug interventions Not Available Not Available recruiting NCT00732498
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL No drug interventions treatment 2 completed NCT01855698
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism No drug interventions Not Available Not Available completed NCT00207298
18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology No drug interventions Not Available Not Available completed NCT05751798
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 / 2 recruiting NCT01921998
Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy No drug interventions Not Available Not Available suspended NCT00290498
Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger treatment 2 completed NCT02349698
A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma No drug interventions treatment 1 / 2 unknown_status NCT00005998
Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease treatment 2 withdrawn NCT00006098
PS-341 in Treating Patients With Hematologic Cancer treatment 1 completed NCT02169505
Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT) No drug interventions treatment 2 terminated NCT00215605
Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies treatment 1 completed NCT00470405
Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT03061305
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors No drug interventions Not Available Not Available recruiting NCT01831505
Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents No drug interventions basic_science 1 completed NCT06421805
Establishing Prospective Mediastinal Tumor Database of PUMCH No drug interventions Not Available Not Available recruiting NCT00304005
VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders No drug interventions treatment 1 / 2 completed NCT00053105
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma treatment 1 unknown_status NCT00002905
Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma treatment 2 unknown_status NCT00004105
Combination Chemotherapy in Treating Patients With Advanced Cancer treatment 1 / 2 completed NCT01065805
A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma No drug interventions diagnostic 1 / 2 terminated NCT00829205
Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment No drug interventions treatment 1 / 2 withdrawn NCT01695005
A Study of LY3039478 in Participants With Advanced Cancer No drug interventions treatment 1 completed NCT00003397
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 completed NCT00445497
Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia No drug interventions supportive_care 3 unknown_status NCT02310997
Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) No drug interventions treatment 2 terminated NCT00295997
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia No drug interventions treatment Not Available unknown_status NCT02663297
Administration of T Lymphocytes for Prevention of Relapse of Lymphomas No drug interventions treatment 1 active_not_recruiting NCT00002697
Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 completed NCT01949883
A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma No drug interventions treatment 1 completed NCT03144583
Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy No drug interventions other 1 completed NCT01844583
Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib No drug interventions treatment 1 completed NCT00466583
Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT00001383
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 treatment 1 completed NCT02559583
Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America No drug interventions Not Available Not Available completed NCT00006083
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter supportive_care 3 completed NCT01953783
Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB No drug interventions treatment 1 completed NCT00001683
A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer treatment 1 completed NCT00055783
Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma treatment 2 completed NCT00911183
Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial No drug interventions treatment 2 completed NCT00010283
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon supportive_care 1 / 2 completed NCT04920383
ALPN-202 With PD-1 Inhibition in Advanced Malignancies No drug interventions treatment 1 terminated NCT01563861
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma No drug interventions Not Available Not Available completed NCT00376961
S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma No drug interventions treatment 2 completed NCT03990961
Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL) No drug interventions treatment 2 active_not_recruiting NCT05150561
Muscle Dysfunction in Patients With Haematological Diseases No drug interventions Not Available Not Available unknown_status NCT00787761
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer No drug interventions treatment 2 completed NCT00278161
Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT02545361
Safety, Tolerability, and Anti-cancer Activity of KAHR-102 (The Study Drug) for the Treatment of Lymphoma Patients No drug interventions treatment 1 / 2 withdrawn NCT00079261
Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma treatment 2 completed NCT06549361
A Retrospective Study on Extranodal DLBCL No drug interventions Not Available Not Available completed NCT00081861
Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma treatment 2 completed NCT00794261
Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma No drug interventions treatment 2 completed NCT01983761
Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation No drug interventions treatment 1 / 2 unknown_status NCT00439361
Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma No drug interventions treatment 1 completed NCT00002461
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma treatment 2 completed NCT00521261
Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma No drug interventions treatment 1 withdrawn NCT00113828
Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies No drug interventions treatment 2 terminated NCT00290628
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer treatment Not Available terminated NCT05852028
A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma No drug interventions Not Available Not Available recruiting NCT00003728
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma treatment 3 unknown_status NCT01551628
A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma No drug interventions treatment 1 terminated NCT00848328
Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma No drug interventions treatment 2 active_not_recruiting NCT00945828
Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors No drug interventions supportive_care Not Available completed NCT05737628
First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228 No drug interventions treatment 1 recruiting NCT01521611
Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy No drug interventions treatment 1 / 2 completed NCT00791011
Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat No drug interventions treatment 1 completed NCT00772811
Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma No drug interventions treatment 2 completed NCT00666211
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain No drug interventions supportive_care 3 completed NCT00716911
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant No drug interventions supportive_care Not Available completed NCT01132911
A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas No drug interventions treatment 1 completed NCT06343311
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) No drug interventions treatment 1 / 2 recruiting NCT00020111
Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma treatment 1 completed NCT00987493
Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma No drug interventions treatment 1 / 2 completed NCT00577993
Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients No drug interventions treatment 3 completed NCT05389293
A Study of Mosunetuzumab in People With Follicular Lymphoma No drug interventions treatment 2 recruiting NCT04214093
A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors No drug interventions treatment 1 terminated NCT01572493
Continuous Infusion of rhIL-15 for Adults With Advanced Cancer No drug interventions treatment 1 completed NCT00002471
Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma treatment 2 completed NCT00002571
SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma treatment 2 completed NCT01988571
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT) No drug interventions prevention 2 completed NCT05683171
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma No drug interventions treatment 1 / 2 recruiting NCT03313271
China Lymphoma Patient Registry Study No drug interventions Not Available Not Available recruiting NCT01829971
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection No drug interventions treatment 1 terminated NCT00562978
Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients No drug interventions treatment 1 / 2 completed NCT01898078
Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT00003578
High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma treatment 3 unknown_status NCT03269578
Sample Collection and Tracking for the Developmental Therapeutics Clinic No drug interventions Not Available Not Available recruiting NCT02347878
Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) No drug interventions prevention 4 unknown_status NCT00451178
A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only No drug interventions treatment 2 completed NCT00074178
Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma treatment 2 completed NCT04188678
Resiliency in Older Adults Undergoing Bone Marrow Transplant No drug interventions other Not Available active_not_recruiting NCT00093678
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer supportive_care Not Available withdrawn NCT02327078
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) No drug interventions treatment 1 / 2 completed NCT00005578
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease treatment 3 completed NCT03229278
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma No drug interventions treatment 1 completed NCT03575078
ARQ761 + PARP Inhibitor in Refractory Solid Tumors No drug interventions treatment 1 withdrawn NCT00002578
Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma treatment 2 completed NCT00003388
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma treatment 2 completed NCT00041288
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL treatment 2 terminated NCT03964688
Effect of Vitamin C in Autologous Stem Cell Transplantations No drug interventions treatment 2 completed NCT06026488
Real-World Study of DLBCL With Different Genetic Subtypes No drug interventions Not Available Not Available not_yet_recruiting NCT04904588
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide No drug interventions treatment 2 recruiting NCT05698888
Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors No drug interventions treatment 1 terminated NCT03245788
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study No drug interventions health_services_research Not Available completed NCT05446688
A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma No drug interventions treatment 2 unknown_status NCT00002488
Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy treatment 2 unknown_status NCT04111107
Precision Medicine for Patients With Identified Actionable Mutations No drug interventions treatment 2 terminated NCT00038207
Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies treatment 2 completed NCT00962507
Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma No drug interventions treatment 1 completed NCT00568607
Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma No drug interventions treatment 2 unknown_status NCT03374007
Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma No drug interventions treatment 1 unknown_status NCT00004107
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia treatment 1 / 2 completed NCT02608307
Medical Treatment Decision Making Using Adaptive Conjoint Analysis No drug interventions Not Available Not Available terminated NCT02436707
Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma No drug interventions treatment 2 recruiting NCT00004907
Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma treatment 1 / 2 completed NCT00012207
Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 1 completed NCT00005609
Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia treatment 2 completed NCT05203809
Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies No drug interventions Not Available Not Available unknown_status NCT00090909
Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma treatment 2 completed NCT03702309
Liquid Biopsy Evaluation and Repository Development at Princess Margaret No drug interventions Not Available Not Available recruiting NCT00695409
Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT01244009
A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002) No drug interventions treatment 2 withdrawn NCT00490009
Phase 2 Study of Bexxar in Relapsed/Refractory DLCL No drug interventions treatment 2 completed NCT04985409
Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant No drug interventions diagnostic Not Available completed NCT00087009
Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation treatment 1 terminated NCT00002909
Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma treatment 1 completed NCT00014209
Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment treatment 2 completed NCT00460109
Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT00472056
Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies No drug interventions treatment 2 completed NCT00958256
Study of Bortezomib in Combination With Cyclophosphamide and Rituximab No drug interventions treatment 2 completed NCT00007956
Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma No drug interventions treatment 1 completed NCT02423356
Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin No drug interventions Not Available Not Available completed NCT00875056
Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103) No drug interventions treatment 2 completed NCT00002956
Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants No drug interventions treatment 1 withdrawn NCT00712556
PET Study in Patients With Non-Hodgkin Lymphoma No drug interventions Not Available Not Available completed NCT00003956
Combination Chemotherapy in Treating Patients With Advanced Cancer treatment 1 completed NCT00561756
Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma No drug interventions treatment 1 completed NCT00056056
Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides treatment 3 terminated NCT00019656
Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer treatment 1 completed NCT01362985
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor No drug interventions Not Available Not Available completed NCT00244985
Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma No drug interventions treatment 1 / 2 completed NCT05049785
Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone No drug interventions supportive_care Not Available active_not_recruiting NCT00569985
Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma No drug interventions treatment 1 completed NCT00450385
Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP) No drug interventions treatment 2 terminated NCT05257785
Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors No drug interventions supportive_care Not Available recruiting NCT06202885
CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy No drug interventions Not Available Not Available active_not_recruiting NCT02269085
Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma No drug interventions treatment 1 terminated NCT02760485
A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma No drug interventions treatment 1 / 2 completed NCT00060385
Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma treatment 2 / 3 terminated NCT05745285
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care No drug interventions supportive_care Not Available not_yet_recruiting NCT05673785
A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL) No drug interventions treatment 2 recruiting NCT00317785
Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases No drug interventions treatment 2 completed NCT06001385
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis No drug interventions treatment 2 recruiting NCT00003815
Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma treatment 3 unknown_status NCT05155215
Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma No drug interventions treatment 1 / 2 unknown_status NCT00587015
A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL) No drug interventions treatment 1 terminated NCT00899015
Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J No drug interventions Not Available Not Available completed NCT00002715
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma treatment 2 completed NCT00740415
Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma No drug interventions treatment 2 completed NCT03271515
Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL No drug interventions treatment 1 unknown_status NCT01160315
Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure No drug interventions prevention 2 / 3 completed NCT00003615
Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 completed NCT00132015
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis treatment 2 completed NCT00089115
Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma treatment 3 terminated NCT04167137
Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants No drug interventions treatment 1 terminated NCT00027937
Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma treatment 2 completed NCT00891137
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy No drug interventions supportive_care 1 completed NCT01906437
Cardiac Fibrosis by CMR in Patients With Cancer No drug interventions Not Available Not Available withdrawn NCT02592837
EBUS-TBNA vs Flex 19G EBUS-TBNA No drug interventions diagnostic Not Available completed NCT02067637
Delayed Effects of Treatment in Cancer Survivors (DETECS) No drug interventions Not Available Not Available withdrawn NCT00265837
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer No drug interventions treatment 3 completed NCT00520637
A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) No drug interventions Not Available 1 completed NCT05770037
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Teenage/Young Adults (TYA) and Paediatric Patients With ALK Positive Cancers No drug interventions treatment 2 / 3 recruiting NCT00294632
Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma No drug interventions treatment 1 / 2 completed NCT00060632
Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED) treatment 1 completed NCT00637832
Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma No drug interventions treatment 2 terminated NCT02062632
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy No drug interventions supportive_care 2 terminated NCT01962532
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT01568632
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma No drug interventions treatment 1 withdrawn NCT00295932
Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma No drug interventions treatment 1 / 2 completed NCT01169532
Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT00098332
Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma treatment 1 completed NCT00306332
T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation No drug interventions treatment 3 terminated NCT00004132
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer supportive_care 2 completed NCT00321932
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant No drug interventions treatment 2 completed NCT01116232
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation No drug interventions supportive_care 2 terminated NCT03054532
Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma No drug interventions treatment 2 unknown_status NCT06294652
AGMT Austrian Lymphoma Registry No drug interventions Not Available Not Available recruiting NCT06203652
The Pathogenesis and Prognostic Factors of Lymphoma No drug interventions Not Available Not Available recruiting NCT00136552
Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden treatment 3 completed NCT02598752
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation No drug interventions Not Available Not Available completed NCT00253552
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders treatment Not Available terminated NCT00003152
Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma treatment 3 terminated NCT01362452
Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells No drug interventions treatment 1 completed NCT01168752
Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma No drug interventions treatment 1 completed NCT01517152
Testing a Spanish Version of a Patient Toxicity Questionnaire No drug interventions Not Available Not Available completed NCT02529852
A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma No drug interventions treatment 1 / 2 completed NCT00851552
Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment No drug interventions treatment 2 terminated NCT00007852
Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 2 completed NCT00002552
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma treatment 2 completed NCT01415752
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma No drug interventions treatment 2 active_not_recruiting NCT00002700
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia treatment 3 completed NCT01755000
Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings No drug interventions supportive_care Not Available completed NCT00049400
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction treatment 1 completed NCT00726700
Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00042900
Pyroxamide in Treating Patients With Advanced Cancer treatment 1 completed NCT01329900
Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas No drug interventions treatment 2 completed NCT00020800
Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia treatment 2 completed NCT00943800
Combined Haploidentical-Cord Blood Transplantation for Adults and Children No drug interventions treatment Not Available completed NCT02145559
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT01555359
Telomerase Activity as a Marker For Mobilization Quality No drug interventions Not Available Not Available unknown_status NCT00387959
Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT00005959
Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma treatment 2 unknown_status NCT05101759
Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy No drug interventions supportive_care Not Available recruiting NCT01139359
Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma No drug interventions treatment 1 withdrawn NCT02898259
Lenalidomide, Ixazomib, and Rituximab as Front-Line Therapy for High Risk Indolent B-Cell Lymphoma No drug interventions treatment 1 / 2 terminated NCT01057459
DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701 No drug interventions Not Available Not Available completed NCT00996359
Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation No drug interventions treatment 1 terminated NCT04931875
Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma No drug interventions Not Available Not Available unknown_status NCT01871675
Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies No drug interventions treatment 1 completed NCT01540175
Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant No drug interventions Not Available Not Available completed NCT00208975
Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab treatment 2 terminated NCT05176275
PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells No drug interventions diagnostic Not Available unknown_status NCT04163575
Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL No drug interventions treatment 1 / 2 unknown_status NCT00030875
Bortezomib in Treating Patients With Mantle Cell Lymphoma treatment 2 completed NCT00004075
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery treatment 1 completed NCT00117975
Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma treatment 2 completed NCT02937675
A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies No drug interventions treatment 1 / 2 terminated NCT00004875
Heparin or Enoxaparin in Patients With Cancer Not Available Not Available completed NCT05967975
Elastography and Treatment of Lymphoma No drug interventions Not Available Not Available not_yet_recruiting NCT00544570
High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma No drug interventions treatment Not Available completed NCT00003270
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00658970
Evaluation of KX2-391 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT00001270
Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma No drug interventions treatment 1 completed NCT00266370
A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma No drug interventions Not Available Not Available unknown_status NCT00188370
Ultrasound Biomicroscopy - Apoptosis No drug interventions diagnostic 2 completed NCT00424242
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases No drug interventions treatment 0 completed NCT00052442
10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma treatment 1 / 2 completed NCT00031642
Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation treatment 1 / 2 completed NCT02766842
Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) No drug interventions diagnostic 2 withdrawn NCT00003942
Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma No drug interventions treatment 1 / 2 unknown_status NCT00066599
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy supportive_care 2 completed NCT06328699
Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation No drug interventions supportive_care Not Available recruiting NCT00517699
A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma. No drug interventions treatment 2 terminated NCT03238599
Pedometer Activity Monitoring After ASCT No drug interventions other 2 completed NCT00049699
VNP40101M in Treating Patients With Advanced or Metastatic Cancer treatment 1 completed NCT00827099
Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer No drug interventions treatment 2 terminated NCT00389506
Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma No drug interventions treatment Not Available withdrawn NCT00005606
Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation No drug interventions treatment 2 completed NCT00275106
Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma treatment 3 terminated NCT00453206
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases No drug interventions treatment Not Available completed NCT00676806
A Phase II Study of Umbilical Cord Blood Transplantation No drug interventions treatment 2 terminated NCT00003406
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer treatment 1 / 2 completed NCT00210249
Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment No drug interventions Not Available Not Available completed NCT01190449
Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00072449
Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma treatment 2 terminated NCT00030849
Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma treatment 2 completed NCT02129049
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children No drug interventions supportive_care Not Available completed NCT01078649
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT00085449
Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer treatment 1 / 2 withdrawn NCT00255749
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer supportive_care 2 completed NCT00990249
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions treatment 2 completed NCT00388349
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease No drug interventions treatment 2 completed NCT06582849
Enhanced Assistance During Radiotherapy for Unmet Essential Needs No drug interventions health_services_research Not Available not_yet_recruiting NCT00719849
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease No drug interventions treatment 2 terminated NCT00032149
Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma treatment 1 / 2 unknown_status NCT00052936
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma treatment 3 completed NCT06084936
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma No drug interventions treatment 3 recruiting NCT00258336
Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma No drug interventions treatment 2 unknown_status NCT00907036
Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma No drug interventions treatment 2 unknown_status NCT06430736
PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) No drug interventions treatment 2 recruiting NCT05275036
Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies No drug interventions Not Available Not Available recruiting NCT00621036
Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma No drug interventions treatment 2 withdrawn NCT00054236
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia treatment 1 completed NCT00025636
Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma treatment 3 unknown_status NCT02948413
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials No drug interventions Not Available Not Available completed NCT02264613
ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 / 2 completed NCT01049113
Safety Study of ON 013105 in Lymphoma and Acute Lymphoid Leukemia No drug interventions treatment 1 terminated NCT00042913
Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 unknown_status NCT00005613
Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease treatment 2 completed NCT00572013
Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma No drug interventions treatment 1 / 2 completed NCT00019513
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas treatment 1 completed NCT04764513
Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT No drug interventions treatment 1 / 2 recruiting NCT02776813
Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma No drug interventions treatment 1 completed NCT05223413
REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs No drug interventions prevention Not Available recruiting NCT00028613
Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma No drug interventions treatment 1 completed NCT01880918
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing No drug interventions Not Available Not Available unknown_status NCT00002618
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma treatment 3 completed NCT04478318
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma No drug interventions basic_science Not Available enrolling_by_invitation NCT00070018
S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma treatment 2 completed NCT00019318
Depsipeptide in Treating Patients With Solid Tumors treatment 1 completed NCT00534118
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant No drug interventions treatment Not Available completed NCT02805218
PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy No drug interventions prevention 4 completed NCT00561418
Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma No drug interventions treatment 1 completed NCT03255018
Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas No drug interventions treatment 2 completed NCT00002818
High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies treatment 1 completed NCT01004718
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT) No drug interventions diagnostic Not Available completed NCT00896519
GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma No drug interventions treatment 2 unknown_status NCT05464719
A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy No drug interventions treatment 2 recruiting NCT00943319
Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies No drug interventions treatment 1 / 2 completed NCT01919619
Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies No drug interventions treatment 1 completed NCT00416819
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma No drug interventions treatment Not Available completed NCT00104819
Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma treatment 2 terminated NCT00032019
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 completed NCT01386619
NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) No drug interventions treatment 1 / 2 completed NCT00498719
Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer No drug interventions Not Available Not Available active_not_recruiting NCT00770419
Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers No drug interventions Not Available Not Available withdrawn NCT00379041
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma No drug interventions treatment 3 active_not_recruiting NCT00290641
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer treatment Not Available completed NCT03959241
TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) No drug interventions prevention 3 completed NCT00031941
CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy treatment 1 completed NCT00006241
Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma treatment 2 completed NCT01581541
PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment No drug interventions treatment 1 terminated NCT00003541
Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma treatment 1 / 2 completed NCT00003741
Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma No drug interventions treatment 1 completed NCT01928017
Thromboelastography, Platelet Function and Platelet Recovery in Haemato-oncologic Patients With Thrombocytopenia No drug interventions Not Available Not Available completed NCT00637117
Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma. No drug interventions treatment 1 / 2 withdrawn NCT00440817
An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease. No drug interventions Not Available Not Available completed NCT01037517
Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization No drug interventions treatment 2 completed NCT00949117
Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer No drug interventions supportive_care 2 terminated NCT04342117
Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL No drug interventions Not Available Not Available terminated NCT00028717
Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma treatment 3 unknown_status NCT00475917
A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies No drug interventions treatment 1 terminated NCT00386217
Psychosocial Impact of Cancer-Related Female Infertility No drug interventions Not Available Not Available completed NCT02836834
Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT06049134
Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy No drug interventions supportive_care 4 recruiting NCT00248534
Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma treatment 2 terminated NCT00086034
Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma treatment 2 completed NCT00392834
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma No drug interventions treatment 2 completed NCT00541034
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT02476734
FDG-PET/CT Imaging as Early Predictor of DP No drug interventions Not Available Not Available completed NCT04306224
A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas No drug interventions treatment 1 completed NCT05179824
Tempus Priority Study: A Pan-tumor Observational Study No drug interventions Not Available Not Available recruiting NCT00274924
Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT06585124
Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas No drug interventions Not Available Not Available recruiting NCT00770224
S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT04977024
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer No drug interventions treatment 2 recruiting NCT00005824
Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma treatment 2 completed NCT01186224
Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC) No drug interventions treatment Not Available unknown_status NCT05858424
Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer No drug interventions supportive_care Not Available recruiting NCT00823524
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer No drug interventions treatment 1 / 2 completed NCT00349024
Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer No drug interventions supportive_care Not Available unknown_status NCT02414724
Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 terminated NCT00003924
Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma treatment 3 unknown_status NCT00416624
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy No drug interventions supportive_care 2 completed NCT00023816
Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma treatment 1 unknown_status NCT01639716
Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers No drug interventions Not Available Not Available completed NCT00651716
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant No drug interventions Not Available Not Available terminated NCT00003116
High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT02905916
The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy No drug interventions prevention 4 unknown_status NCT00737516
Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation No drug interventions Not Available 2 completed NCT02916316
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell No drug interventions Not Available Not Available active_not_recruiting NCT00003416
S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia treatment 2 completed NCT03654716
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer No drug interventions treatment 1 completed NCT00612716
Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT00482716
Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer No drug interventions supportive_care 3 unknown_status NCT03494296
A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL No drug interventions Not Available Not Available recruiting NCT00096096
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation supportive_care 2 completed NCT00053196
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer treatment 2 completed NCT00574496
Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma No drug interventions treatment 2 completed NCT03682796
Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma No drug interventions treatment 1 completed NCT00242996
Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma treatment 2 completed NCT00547196
AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders No drug interventions treatment Not Available completed NCT00886496
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia No drug interventions supportive_care 1 withdrawn NCT06471296
Virus-associated Tumour Microenvironment No drug interventions Not Available Not Available not_yet_recruiting NCT06563596
Epcoritamab, Zanubrutinib, and Rituximab (EZR) for R/R FL Relapsed or Refractory Follicular Lymphoma No drug interventions treatment 2 not_yet_recruiting NCT00062296
Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT01021358
A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax). No drug interventions treatment 1 completed NCT03361358
Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma No drug interventions Not Available Not Available completed NCT01000558
SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma No drug interventions Not Available Not Available completed NCT00003658
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers treatment 2 completed NCT00670358
Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma No drug interventions treatment 1 / 2 active_not_recruiting NCT00004258
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer treatment 1 completed NCT02518958
A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab No drug interventions treatment 1 completed NCT03794635
An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer No drug interventions other Not Available active_not_recruiting NCT00486135
Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT01051635
A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT01998035
Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies No drug interventions treatment 1 / 2 terminated NCT00003335
Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer treatment 2 completed NCT01532635
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives No drug interventions treatment 2 terminated NCT00002563
SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease No drug interventions Not Available Not Available completed NCT00971763
Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma No drug interventions treatment 2 completed NCT00003163
Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers treatment 2 unknown_status NCT00719563
American Ginseng in Treating Patients With Fatigue Caused by Cancer No drug interventions supportive_care 3 completed NCT00003863
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma No drug interventions Not Available Not Available completed NCT00003663
Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma treatment 2 withdrawn NCT05763563
Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy No drug interventions supportive_care Not Available recruiting NCT00955786
Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT00359086
Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma No drug interventions treatment 2 completed NCT00989586
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma No drug interventions treatment 1 / 2 completed NCT01236586
RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia No drug interventions treatment 1 withdrawn NCT00884286
Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00574886
Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy No drug interventions treatment Not Available completed NCT00364286
Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825) No drug interventions treatment 2 completed NCT00001686
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases No drug interventions Not Available Not Available completed NCT00664586
A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors No drug interventions treatment 1 terminated NCT03722186
Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies No drug interventions treatment 1 suspended NCT00004086
Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer treatment 1 unknown_status NCT00754286
A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer No drug interventions supportive_care Not Available completed NCT00121186
S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma treatment 2 terminated NCT00049439
Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma treatment 2 completed NCT02580539
A Study of the Safety and Efficacy of EBV Specific T-cell Lines No drug interventions treatment 1 / 2 recruiting NCT00003039
Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma treatment 2 completed NCT01050439
Unrelated Donor Transplant for Malignant and Non-Malignant Disorders No drug interventions treatment 2 terminated NCT02392039
Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma No drug interventions treatment 0 terminated NCT00005639
Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment treatment 1 completed NCT00800839
Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide No drug interventions treatment 2 completed NCT04053439
Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications No drug interventions Not Available Not Available recruiting NCT00646139
KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment No drug interventions treatment 1 completed NCT00045539
Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma treatment 2 completed NCT04837222
A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma No drug interventions Not Available Not Available recruiting NCT00506922
Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT No drug interventions treatment 1 / 2 completed NCT01567722
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies No drug interventions Not Available Not Available terminated NCT00002522
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma treatment 2 completed NCT03314922
A Study of INCB050465 in Japanese Subjects With Previously Treated B-Cell Lymphoma (CITADEL-111) No drug interventions treatment 1 completed NCT00058422
Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma treatment 2 completed NCT04980222
A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma No drug interventions treatment 2 active_not_recruiting NCT01445522
ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer No drug interventions treatment 1 completed NCT00904722
Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma No drug interventions treatment 2 completed NCT00042822
FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma treatment 2 completed NCT05093322
A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors No drug interventions treatment 1 / 2 completed NCT00006125
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma treatment 2 completed NCT02783625
Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas No drug interventions treatment 1 active_not_recruiting NCT00086125
Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED) treatment 2 completed NCT01240525
Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers No drug interventions treatment 2 unknown_status NCT04610125
Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children No drug interventions treatment Not Available recruiting NCT00002625
Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma treatment 1 completed NCT00854425
L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma No drug interventions treatment 2 completed NCT00788125
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors No drug interventions treatment 1 / 2 terminated NCT03121625
CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies No drug interventions treatment 1 unknown_status NCT01939730
Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma No drug interventions treatment 2 completed NCT00517530
A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN) No drug interventions treatment 1 / 2 completed NCT00248430
Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer treatment 1 / 2 completed NCT06557330
MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma No drug interventions diagnostic 2 not_yet_recruiting NCT01029730
Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma No drug interventions treatment 2 completed NCT03407430
Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain No drug interventions prevention 2 terminated NCT00591630
Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation No drug interventions treatment 2 completed NCT01697930
A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) No drug interventions diagnostic 1 recruiting NCT00726830
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer No drug interventions supportive_care Not Available terminated NCT03179930
Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas No drug interventions treatment 2 active_not_recruiting NCT00028730
Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer treatment 2 completed NCT03556748
WB-EMS and Nutrition in Patients With Hematological Malignancies No drug interventions supportive_care Not Available unknown_status NCT01016548
Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy No drug interventions Not Available 3 completed NCT02056548
Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy No drug interventions Not Available Not Available unknown_status NCT05444348
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) No drug interventions supportive_care Not Available recruiting NCT00066248
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment supportive_care 2 completed NCT02935348
Whole Body PET-MRI in Paediatric and Adolescent Lymphoma No drug interventions Not Available Not Available unknown_status NCT00506948
Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD) No drug interventions treatment 2 terminated NCT06067048
Zanubrutinib in Primary Cold Agglutinin Disease No drug interventions treatment 2 not_yet_recruiting NCT00002657
SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant treatment 2 completed NCT01095757
Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection No drug interventions treatment 2 completed NCT00410657
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant No drug interventions supportive_care 2 completed NCT00073957
Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma treatment 2 completed NCT03602157
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL No drug interventions treatment 1 recruiting NCT05341557
A Phase 1 Study of BPI-371153 in Subjects With Advanced Solid Tumors or Relapsed/Refractory Lymphoma No drug interventions treatment 1 not_yet_recruiting NCT03212157
GlucoCEST MRI in Oncology No drug interventions basic_science Not Available completed NCT00002757
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma treatment 3 completed NCT00004057
Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas treatment 1 completed NCT00427557
Cellular Therapy With Cord Blood Cells No drug interventions treatment 2 completed NCT03747757
Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue No drug interventions supportive_care 2 active_not_recruiting NCT00003957
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma treatment 2 completed NCT00053157
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia supportive_care Not Available completed NCT00898157
Study of Biomarkers Using Tissue Samples From Older Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab on Clinical Trial ECOG-E4494 No drug interventions Not Available Not Available completed NCT00002557
Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides treatment 2 unknown_status NCT03953326
HeartPhone Cancer Survivors Trial 2019 No drug interventions prevention 1 / 2 terminated NCT01986426
LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab No drug interventions treatment 1 completed NCT03373526
Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation No drug interventions treatment Not Available unknown_status NCT01682226
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies No drug interventions treatment 2 completed NCT01118026
Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00234026
Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma treatment 2 completed NCT00951626
A Standardized Nursing Intervention Protocol for HCT Patients No drug interventions health_services_research Not Available completed NCT01319526
Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy No drug interventions Not Available Not Available terminated NCT00014326
Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma No drug interventions treatment 3 terminated NCT02857426
A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) No drug interventions treatment 2 completed NCT06047626
Living Well With Lymphoma No drug interventions supportive_care Not Available recruiting NCT00574626
Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma No drug interventions treatment Not Available completed NCT00898066
S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease No drug interventions Not Available Not Available completed NCT04556266
A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies No drug interventions treatment 1 withdrawn NCT02793466
Durvalumab in Pediatric and Adolescent Patients No drug interventions treatment 1 completed NCT00028665
Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma treatment 2 completed NCT01926665
Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL) No drug interventions treatment 1 completed NCT00074165
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen treatment 2 terminated NCT02291965
Blood Samples to Identify Biomarkers of Busulfan No drug interventions Not Available Not Available active_not_recruiting NCT00020865
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia supportive_care 3 unknown_status NCT04737265
Pilot Study of an NTproBNP Guided Strategy of Cardioprotection No drug interventions prevention 1 / 2 active_not_recruiting NCT00559065
A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China No drug interventions Not Available Not Available completed NCT00345865
Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT00002565
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma treatment 3 completed NCT02710565
Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma No drug interventions basic_science Not Available completed NCT00686465
Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study No drug interventions treatment Not Available completed NCT03422874
Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 withdrawn NCT00004874
Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma No drug interventions treatment 3 terminated NCT03515174
Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO No drug interventions supportive_care Not Available active_not_recruiting NCT00003874
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia No drug interventions treatment 1 / 2 completed NCT00513474
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant No drug interventions supportive_care 1 completed NCT01563874
Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins No drug interventions Not Available Not Available completed NCT03458520
Pediatric PET/MR Image Registry No drug interventions Not Available Not Available recruiting NCT01352520
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) No drug interventions treatment 2 active_not_recruiting NCT01323920
Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors No drug interventions treatment 2 completed NCT00304720
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor No drug interventions treatment 2 unknown_status NCT00006220
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy treatment 1 / 2 terminated NCT00881920
Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL No drug interventions treatment 1 recruiting NCT00744120
Lymphoma Follow-up No drug interventions Not Available Not Available completed NCT01382082
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy No drug interventions Not Available Not Available enrolling_by_invitation NCT01406782
DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402 No drug interventions Not Available Not Available completed NCT00410982
Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies No drug interventions treatment 1 completed NCT03815682
RPTR-147 in Patients With Selected Solid Tumors and Lymphomas No drug interventions treatment 1 terminated NCT00007982
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer treatment 2 completed NCT00002682
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach treatment 2 completed NCT04797182
Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma No drug interventions prevention 2 unknown_status NCT02488382
Lonquek for Autologous Stem Cell Mobilization No drug interventions treatment 1 / 2 unknown_status NCT02728882
Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma No drug interventions treatment Not Available unknown_status NCT02795182
Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies No drug interventions treatment 1 completed NCT00305682
Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant No drug interventions treatment 2 completed NCT00070382
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer supportive_care 3 completed NCT01877382
A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT00002982
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma treatment 2 completed NCT00109031
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) supportive_care 3 completed NCT06441331
Phase I Trial to Determine the Dose and Evaluate the PK of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors No drug interventions treatment 1 not_yet_recruiting NCT00005631
Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma treatment 2 completed NCT00924131
Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial No drug interventions Not Available Not Available completed NCT00004031
SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma treatment 3 completed NCT00796731
SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma No drug interventions treatment 1 completed NCT00801931
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders No drug interventions treatment 1 / 2 terminated NCT05362331
Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy No drug interventions health_services_research Not Available withdrawn NCT00660231
Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00727831
Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma No drug interventions treatment 1 / 2 completed NCT00003331
Combination Chemotherapy in Treating Patients With Advanced Cancer treatment 1 completed NCT00004231
Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma treatment 2 completed NCT00073931
Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 2 completed NCT01383473
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients No drug interventions Not Available Not Available completed NCT00933673
New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma No drug interventions treatment 2 unknown_status NCT00003073
Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors treatment 1 unknown_status NCT00496873
Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan No drug interventions treatment 2 completed NCT00734773
Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL No drug interventions treatment 0 withdrawn NCT02701673
Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma No drug interventions treatment 1 / 2 withdrawn NCT00678327
Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma No drug interventions treatment 3 completed NCT00002827
Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease treatment 3 completed NCT00054327
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer treatment 2 completed NCT03235427
The CAROLE (CArdiac Related Oncologic Late Effects) Study No drug interventions Not Available Not Available completed NCT00320827
Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) No drug interventions treatment 1 completed NCT00019227
Monoclonal Antibody Therapy in Treating Patients With Leukemia treatment 1 / 2 completed NCT00041327
Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma treatment 2 completed NCT00933127
S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone No drug interventions Not Available Not Available completed NCT00787527
SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma No drug interventions treatment 1 / 2 completed NCT06345027
CHIMERIC ANTIGEN RECEPTOR TREATMENT TARGETING CD70 (SEVENTY) No drug interventions treatment 1 not_yet_recruiting NCT05019976
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma No drug interventions treatment Not Available recruiting NCT02998476
A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202) No drug interventions treatment 2 completed NCT00002576
Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma treatment 3 completed NCT05646576
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy No drug interventions supportive_care Not Available recruiting NCT04706676
Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer No drug interventions prevention Not Available recruiting NCT00810576
Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma No drug interventions treatment 2 terminated NCT00002676
Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma treatment 2 completed NCT06106776
CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study No drug interventions Not Available Not Available not_yet_recruiting NCT03167476
Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma No drug interventions Not Available Not Available unknown_status NCT00009776
Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma treatment 1 unknown_status NCT06153576
The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures No drug interventions Not Available Not Available completed NCT01454076
Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma No drug interventions treatment 1 completed NCT00301860
Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer treatment Not Available terminated NCT00004260
Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma treatment 1 completed NCT03480360
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression No drug interventions treatment 3 active_not_recruiting NCT02588560
Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy No drug interventions Not Available Not Available unknown_status NCT00262860
Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT03488160
CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma No drug interventions treatment Not Available unknown_status NCT00460460
Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies No drug interventions treatment 1 terminated NCT00690560
Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma No drug interventions treatment 2 completed NCT00968760
CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies No drug interventions treatment 1 completed NCT00002494
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia treatment 2 completed NCT00993694
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone No drug interventions Not Available Not Available completed NCT00077194
FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 2 completed NCT00588094
Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL No drug interventions treatment 2 completed NCT00359294
A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma No drug interventions treatment 1 terminated NCT00003294
Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer treatment 1 completed NCT02605694
Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO) No drug interventions treatment 2 withdrawn NCT05479994
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No drug interventions treatment 2 recruiting NCT00060294
Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia treatment 1 terminated NCT04910594
Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma No drug interventions treatment 3 unknown_status NCT00074191
Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma treatment 2 completed NCT00002691
Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma treatment 2 completed NCT05288491
A Study of Chinese Adults With Lymphoma No drug interventions Not Available Not Available completed NCT01147991
Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer No drug interventions treatment 1 completed NCT00133991
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia treatment 2 completed NCT03465891
Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma No drug interventions treatment 2 terminated NCT05878691
A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. No drug interventions treatment 1 active_not_recruiting NCT01779791
A Study of PCI-32765 (Ibrutinib) in Patients With Refractory Follicular Lymphoma No drug interventions treatment 2 completed NCT05063591
Removing Transfusion Dependence as a Barrier to Hospice Enrollment No drug interventions supportive_care Not Available active_not_recruiting NCT00020462
Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma treatment 1 completed NCT01750762
Lenalidomide After Allo Transplant No drug interventions treatment 1 terminated NCT00006362
PS-341 in Treating Patients With Advanced Cancer treatment 1 completed NCT01774162
EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration No drug interventions diagnostic Not Available completed NCT00002462
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease treatment 3 active_not_recruiting NCT00002862
Perillyl Alcohol in Treating Patients With Refractory Cancer treatment 1 completed NCT00003280
Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma treatment 3 completed NCT00024180
FR901228 in Treating Patients With Hematologic Cancer treatment 1 completed NCT01658280
Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies No drug interventions diagnostic 4 completed NCT03118180
CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma No drug interventions treatment 1 / 2 unknown_status NCT00107380
S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma treatment 2 completed NCT00005580
Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma treatment 1 completed NCT00299780
Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. No drug interventions treatment 1 completed NCT00002980
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer treatment 1 completed NCT06010680
A Study to Evaluate the Mass Balance of [14C]SHR2554 in Healthy Adult Volunteers No drug interventions other 1 completed NCT00061880
BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma treatment 1 / 2 completed NCT02932280
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment No drug interventions treatment 1 / 2 active_not_recruiting NCT00562380
AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma No drug interventions treatment 1 completed NCT00026429
Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 unknown_status NCT00002829
Bone Marrow Transplantation in Treating Patients With Lymphoma treatment 2 completed NCT00667329
Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab No drug interventions treatment 1 completed NCT01846429
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain No drug interventions supportive_care 1 terminated NCT02014129
A Study of LY2835219 in Japanese Participants With Advanced Cancer No drug interventions treatment 1 completed NCT01135329
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers No drug interventions treatment 2 terminated NCT01200329
High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease No drug interventions treatment 2 completed NCT00006029
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma treatment 1 / 2 completed NCT00476229
Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies No drug interventions treatment Not Available completed NCT00857389
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies No drug interventions treatment 2 completed NCT01441089
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis No drug interventions Not Available Not Available recruiting NCT00004189
Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer treatment 1 completed NCT03098589
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) No drug interventions Not Available Not Available unknown_status NCT02963389
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients No drug interventions prevention 1 completed NCT00003389
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma treatment 3 completed NCT06262789
RAT-HEMATO : Return to Work After Malignant Hemopathy No drug interventions supportive_care Not Available not_yet_recruiting NCT04037189
Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia No drug interventions Not Available Not Available unknown_status NCT04822389
Telerehabilitation and Lymphoma Patients No drug interventions supportive_care Not Available completed NCT03058289
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 No drug interventions treatment 1 / 2 completed NCT00053989
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders treatment 2 completed NCT01354392
AZD1152 in Diffuse Large B-cell Lymphoma No drug interventions treatment 1 / 2 completed NCT00066092
Pegfilgrastim PBPC Mobilization Study treatment 2 completed NCT02221492
Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00053092
Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma treatment 2 completed NCT04970992
A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma No drug interventions treatment 1 recruiting NCT00974792
Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma No drug interventions treatment 2 unknown_status NCT03249792
Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001) No drug interventions treatment 1 terminated NCT00955292
Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 terminated NCT01307592
Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma No drug interventions treatment 2 unknown_status NCT00004192
Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma supportive_care 2 completed NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions No drug interventions Not Available Not Available completed NCT00019344
Flavopiridol in Treating Patients With Refractory Cancer treatment 1 completed NCT01410344
Allogeneic Transplant in HIV Patients (BMT CTN 0903) No drug interventions treatment 2 completed NCT02108444
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients No drug interventions Not Available Not Available completed NCT00621244
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies No drug interventions treatment 1 / 2 completed NCT00038844
Safety and Efficacy of Campath in Nonmyeloablative Transplantation treatment Not Available completed NCT00983944
Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma No drug interventions treatment 2 withdrawn NCT01394640
Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients No drug interventions Not Available Not Available completed NCT00062140
Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT01077440
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant No drug interventions Not Available Not Available terminated NCT03793140
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations No drug interventions treatment 2 active_not_recruiting NCT00361140
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) No drug interventions treatment 4 completed NCT03295240
The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma No drug interventions treatment 0 completed NCT00055640
Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma treatment 2 completed NCT00755040
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder No drug interventions prevention 3 completed NCT00500240
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) No drug interventions treatment 3 terminated NCT04144140
Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 No drug interventions treatment 1 terminated NCT00186940
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients Not Available Not Available completed NCT00002940
Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS treatment 2 completed NCT05540340
A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant No drug interventions treatment 1 recruiting NCT01234467
Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma No drug interventions treatment 2 completed NCT00740467
Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders No drug interventions treatment 2 unknown_status NCT00310167
Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma No drug interventions treatment 3 completed NCT01471067
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies No drug interventions treatment 1 completed NCT06409767
Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation. No drug interventions treatment Not Available not_yet_recruiting NCT00057967
Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome treatment 2 completed NCT06270667
Effects of Exercise Training in Survivors of Lymphoma No drug interventions prevention Not Available recruiting NCT00493467
Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas No drug interventions treatment 2 completed NCT00005967
Tipifarnib in Treating Patients With Advanced Hematologic Cancer treatment 1 completed NCT02858167
Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations No drug interventions Not Available Not Available completed NCT03809767
A Study of CS1003 in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT02257567
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma No drug interventions treatment 1 / 2 completed NCT01073267
Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides No drug interventions treatment 2 completed NCT02323867
Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies No drug interventions treatment 2 recruiting NCT04106167
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy No drug interventions Not Available Not Available terminated NCT00003567
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma treatment 1 terminated NCT00972101
Infusion of Expanded Cord Blood T Cells No drug interventions treatment 1 withdrawn NCT01490801
Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma No drug interventions Not Available Not Available completed NCT06131801
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution No drug interventions Not Available Not Available recruiting NCT00813501
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases No drug interventions Not Available Not Available terminated NCT02389101
Molecular and Whole-body MR Imaging in Lymphomas No drug interventions diagnostic Not Available completed NCT00450801
R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma No drug interventions treatment 2 completed NCT00561301
Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma No drug interventions treatment 2 unknown_status NCT00004101
Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma treatment 1 completed NCT01624701
Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells No drug interventions treatment 1 / 2 terminated NCT00448201
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease No drug interventions treatment 2 completed NCT00553501
Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT01111201
International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients No drug interventions Not Available Not Available completed NCT00127101
An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED) treatment 1 terminated NCT00085904
Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas treatment 1 completed NCT03226704
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing No drug interventions Not Available Not Available enrolling_by_invitation NCT00559104
Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00070304
Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma treatment 2 completed NCT02724904
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma No drug interventions treatment 1 / 2 withdrawn NCT00004904
Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT00504504
Rituximab and ABVD for Hodgkin's Patients No drug interventions treatment 2 completed NCT00093704
Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma treatment 1 terminated NCT00290004
Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma treatment 1 / 2 completed NCT05952804
IVIG for Infection Prevention After CAR-T-Cell Therapy No drug interventions prevention 2 recruiting NCT01287104
A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias No drug interventions treatment 1 completed NCT00963872
Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer No drug interventions treatment 1 / 2 terminated NCT00898872
SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial No drug interventions Not Available Not Available completed NCT00003572
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers treatment 2 completed NCT00939172
TTP607 in Refractory Solid Malignancies No drug interventions treatment 1 withdrawn NCT00052572
Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders treatment 2 completed NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05940272
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers No drug interventions Not Available Not Available recruiting NCT01362972
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor No drug interventions Not Available Not Available completed NCT05296772
Phase 1 First-in-human Study of JS014 No drug interventions treatment 1 recruiting NCT04818372
Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma No drug interventions treatment 1 unknown_status NCT00021372
Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 2 completed NCT05251168
PET Guided Bone Marrow Biopsy vs Trephine Bone Marrow Biopsy No drug interventions Not Available Not Available completed NCT00499668
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer No drug interventions supportive_care Not Available withdrawn NCT01149668
A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer No drug interventions treatment 1 completed NCT00772668
Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL No drug interventions treatment Not Available terminated NCT06053268
Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors No drug interventions treatment Not Available enrolling_by_invitation NCT00815568
Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) No drug interventions treatment 2 unknown_status NCT03983668
CMP-001 for Relapsed and Refractory Lymphoma No drug interventions treatment 1 / 2 suspended NCT02383368
A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma No drug interventions treatment 1 completed NCT00562068
Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma No drug interventions treatment 1 unknown_status NCT00003368
Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis treatment 1 completed NCT00659568
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma No drug interventions treatment 1 completed NCT00093769
Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 completed NCT01983969
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma No drug interventions treatment 1 / 2 completed NCT02419469
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma No drug interventions treatment 2 terminated NCT00234169
A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone treatment 1 / 2 completed NCT01889069
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL) No drug interventions treatment 3 completed NCT00863369
Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma No drug interventions treatment 1 / 2 completed NCT05250869
Comparative Quantification of MTX and Its Metabolites Post Glucarpidase No drug interventions Not Available Not Available completed NCT03489369
Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas No drug interventions treatment 1 completed NCT00901069
Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma No drug interventions treatment 1 completed NCT00787969
Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma No drug interventions treatment 1 completed NCT05892146
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction No drug interventions prevention Not Available recruiting NCT01520246
Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT02370446
Testing a Personalize Medication Log for Patients With Lymphoma No drug interventions Not Available Not Available completed NCT00005946
Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation treatment 1 completed NCT00126646
BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma No drug interventions treatment 1 completed NCT05655546
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals No drug interventions other Not Available active_not_recruiting NCT06070246
Navigating the Clinical Research Process for Lymphoma No drug interventions Not Available Not Available not_yet_recruiting NCT00113646
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies treatment 2 terminated NCT00068146
Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma No drug interventions Not Available Not Available completed NCT00602446
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant No drug interventions supportive_care 2 terminated NCT03574012
SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart No drug interventions prevention Not Available completed NCT04386512
Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1) No drug interventions Not Available Not Available completed NCT00001512
Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines No drug interventions treatment 1 completed NCT05929612
A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma No drug interventions treatment 2 recruiting NCT02287012
Quantification of the Time and Effort Required for Peripheral Blood Stem Cell Collection -The European Perspective No drug interventions Not Available Not Available completed NCT01751412
Proton Radiation for Lymphoma Involving Mediastinum No drug interventions treatment Not Available terminated NCT03311412
Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas No drug interventions treatment 1 completed NCT00669812
High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma No drug interventions treatment 2 unknown_status NCT01505712
Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial No drug interventions Not Available Not Available completed NCT01101412
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies No drug interventions supportive_care 1 / 2 withdrawn NCT00004212
DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas treatment 1 completed NCT00049712
Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma treatment 1 completed NCT00416312
Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma No drug interventions Not Available Not Available completed NCT00036712
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation No drug interventions supportive_care 2 unknown_status NCT00041210
Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma treatment 3 unknown_status NCT00004010
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease treatment 2 completed NCT03187210
Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas No drug interventions treatment 1 / 2 suspended NCT03841110
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03223610
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma No drug interventions treatment 1 / 2 recruiting NCT00002510
Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma treatment 1 / 2 completed NCT04094610
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations No drug interventions treatment 1 / 2 recruiting NCT00854581
Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma No drug interventions treatment 4 terminated NCT00589381
Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT03769181
A Study of Isatuximab-based Therapy in Participants With Lymphoma No drug interventions treatment 1 / 2 terminated NCT01557881
Positron Emission Tomography/Magnetic Resonance Imaging in Patients No drug interventions diagnostic Not Available terminated NCT00002681
Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma treatment 1 / 2 completed NCT00005881
Quality of Life in Children Treated for Cancer No drug interventions Not Available Not Available completed NCT03969381
Diffusion-weighted Magnetic Resonance Imaging in Post Therapy Patients With Lymphoma No drug interventions Not Available Not Available unknown_status NCT00641381
Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma No drug interventions treatment 1 active_not_recruiting NCT00880581
A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas No drug interventions treatment 2 completed NCT01956695
Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma No drug interventions treatment 2 completed NCT02520895
Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia No drug interventions Not Available Not Available completed NCT00292695
A Phase II Study of Nasal NK/T-cell Lymphoma No drug interventions treatment 2 completed NCT00227695
Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma No drug interventions treatment 3 completed NCT00641095
Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma No drug interventions treatment 2 / 3 completed NCT00006695
Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma treatment 2 completed NCT00049595
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma treatment 3 completed NCT00980395
Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma No drug interventions treatment 2 completed NCT00003595
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma treatment 3 completed NCT03934814
Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma No drug interventions treatment 1 completed NCT00002714
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease treatment 2 completed NCT02260414
Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer No drug interventions basic_science 2 completed NCT00757614
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom No drug interventions Not Available Not Available unknown_status NCT05754814
SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes No drug interventions Not Available Not Available recruiting NCT00665314
Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM). No drug interventions treatment 2 completed NCT00003114
Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease treatment 2 completed NCT04158414
Applying PET/MR in Oncology - a Prospective Project No drug interventions diagnostic Not Available unknown_status NCT00062114
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 completed NCT00281814
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant No drug interventions Not Available Not Available completed NCT00071955
Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma treatment 2 completed NCT03260855
Evaluation Study of Fear of Cancer Recurrence: Detection, Measure and Risk Factors in Lymphoma Survivorship No drug interventions prevention Not Available completed NCT02072655
Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization No drug interventions supportive_care Not Available completed NCT05095155
Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality No drug interventions Not Available Not Available completed NCT02595255
AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE) No drug interventions Not Available Not Available recruiting NCT00002750
Melphalan in Patients With Neoplastic Meningitis treatment 1 completed NCT00040950
Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 1 completed NCT02456350
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies No drug interventions treatment 1 unknown_status NCT00068250
Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma treatment 1 / 2 completed NCT05676450
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas No drug interventions diagnostic Not Available recruiting NCT00085150
LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma No drug interventions treatment 1 completed NCT01855750
A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma No drug interventions treatment 3 completed NCT03435250
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss No drug interventions treatment 1 terminated NCT00006250
Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma treatment 3 unknown_status NCT00705250
Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma No drug interventions treatment 2 completed NCT00006350
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00800150
Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment No drug interventions treatment 1 terminated NCT01088750
Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma No drug interventions treatment 4 completed NCT05179850
Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children No drug interventions Not Available Not Available unknown_status NCT03544723
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors. No drug interventions treatment 2 unknown_status NCT00033423
Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 1 terminated NCT05982223
Integrative Medicine in Lymphoma Survivors No drug interventions supportive_care Not Available recruiting NCT00052923
Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma treatment 3 completed NCT02593123
Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis No drug interventions treatment 2 completed NCT01490723
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) No drug interventions treatment 2 completed NCT02503423
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 / 2 active_not_recruiting NCT01479023
Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT00003423
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma treatment 3 unknown_status NCT02889523
Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy No drug interventions treatment 1 / 2 active_not_recruiting NCT00387023
Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma No drug interventions treatment Not Available completed NCT00255723
Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma treatment 2 completed NCT00104923
Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer treatment 1 completed NCT00002908
Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT00868608
Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma No drug interventions treatment 2 completed NCT00889408
DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma No drug interventions treatment 1 completed NCT00004908
Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma treatment 2 completed NCT04460508
Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma No drug interventions prevention 2 unknown_status NCT00317408
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma No drug interventions treatment Not Available unknown_status NCT00278408
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma No drug interventions treatment 3 completed NCT00026208
Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma treatment 2 completed NCT00003338
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma No drug interventions diagnostic 2 / 3 unknown_status NCT00920738
Metabolic Syndrome in Childhood Cancer Survivors No drug interventions Not Available Not Available completed NCT00019838
UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia treatment 1 completed NCT05388838
Screening for Oculocerebral Lymphoma With the Phenotype of NK Cells in Patients With Uveitis No drug interventions diagnostic Not Available recruiting NCT02885038
Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies No drug interventions Not Available Not Available completed NCT00526838
Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies No drug interventions treatment 1 terminated NCT00360438
Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS No drug interventions treatment 1 / 2 completed NCT00238238
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab treatment 2 completed NCT04571138
A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma No drug interventions treatment 1 / 2 recruiting NCT01150643
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab No drug interventions Not Available Not Available completed NCT00248443
Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage No drug interventions diagnostic 3 completed NCT00352443
S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma No drug interventions treatment 1 completed NCT00020943
Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma treatment 2 completed NCT04132843
Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions No drug interventions diagnostic Not Available completed NCT03135743
Retrospective Analysis of Lymphomas and Cancers Synchronous Occurrence in Picardy From 2007 to 2012 No drug interventions Not Available Not Available unknown_status NCT01861093
Safety Study of Cord Blood Units for Stem Cell Transplants No drug interventions treatment 2 recruiting NCT04590820
Oral Tazemetostat in Combination With Rituximab in R/R FL treatment 2 terminated NCT02751554
PET Imaging of Patients Using 124I-PU-AD No drug interventions diagnostic Not Available recruiting NCT00960050
Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone No drug interventions Not Available 1 unknown_status NCT02055040
Detection of Cardiac Fibrosis in Patients With Lymphoma No drug interventions diagnostic 0 unknown_status NCT01999491
A Phase 1 Dose-Escalation and Pharmacokinetic Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 active_not_recruiting NCT00810966
ABT-888 and Cyclophosphamide in Treating Patients With Solid Tumors or Lymphoma That Did Not Respond to Previous Therapy treatment 1 active_not_recruiting NCT00445666
Tumor-Infiltrating Lymphocytes in Treating Patients With Persistent or Recurrent B-Cell Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Multiple Myeloma After a Previous Donor Stem Cell Transplant No drug interventions treatment 1 active_not_recruiting NCT00066300
Allogeneic Peripheral Stem Cell Transplantation Followed By Donor Lymphocyte Infusions in Treating Patients With Hematologic Cancer treatment 2 active_not_recruiting NCT01065025
Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT01626547
Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology No drug interventions Not Available Not Available completed NCT01212341
Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor No drug interventions treatment 1 completed NCT01800630
Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas No drug interventions other 1 completed NCT05545202
A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation No drug interventions treatment 4 not_yet_recruiting NCT00509184
Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma No drug interventions treatment 2 completed NCT04760184
Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden No drug interventions Not Available Not Available completed NCT02916979
Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG No drug interventions treatment 1 completed NCT04986293
CPAP or BiPAP for Motion Mitigation During Radiotherapy No drug interventions other Not Available recruiting NCT00741871
A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies No drug interventions treatment 1 completed NCT02440685
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors treatment 1 / 2 terminated NCT00078637
Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma treatment 1 completed NCT03346096
TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in Lymphoma treatment 2 completed NCT01789060
p-AKT Expression on Clinical Outcomes in Malignant Lymphoma No drug interventions Not Available Not Available completed NCT05515029
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis treatment 3 active_not_recruiting NCT02441972
Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics No drug interventions diagnostic 1 unknown_status NCT01324310
Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer No drug interventions other 1 completed NCT01473095
Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma No drug interventions treatment 1 completed NCT01016795
Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma No drug interventions treatment 2 terminated NCT00146055
Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood No drug interventions treatment 2 completed NCT04464590
Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT No drug interventions Not Available Not Available completed NCT00892502
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? No drug interventions treatment Not Available completed NCT02846584
a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies No drug interventions treatment 2 unknown_status NCT00619879
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies No drug interventions treatment 3 unknown_status NCT03359733
A Study to Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor No drug interventions other 1 withdrawn NCT01432951
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma No drug interventions other 1 completed NCT00600353
Multi-day Doses in Prevention of Nausea and Emesis No drug interventions supportive_care 2 completed NCT01499147
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies No drug interventions treatment Not Available completed NCT00685997
Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas No drug interventions Not Available Not Available completed NCT02131688
Phase I Study of Mitoxantrone Hydrochloride Liposome Injection No drug interventions treatment 1 unknown_status NCT02732275
DS-3201b in Participants With Lymphomas No drug interventions treatment 1 active_not_recruiting NCT02678299
Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN Study No drug interventions treatment 1 / 2 active_not_recruiting NCT04947618
Efficacy of Patient Management for Lymphoma Diagnosed at Nimes University Hospital From 1999 to 2018. DVR-Lym-Nim No drug interventions Not Available Not Available recruiting NCT05827341
A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials No drug interventions Not Available Not Available completed NCT04698616
Lean Body Mass and Side Effects in Patients With Lymphoma No drug interventions Not Available Not Available unknown_status NCT01388335
A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin No drug interventions other 1 completed NCT05190263
Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma No drug interventions Not Available Not Available completed NCT01588548
Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma No drug interventions treatment 1 completed NCT06475820
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis No drug interventions treatment 2 / 3 active_not_recruiting NCT00037791
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia No drug interventions prevention 3 completed NCT02249429
Open-Label, Non Randomized Phase 2 Study With Safety Run-In No drug interventions treatment 2 completed NCT04464889
HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation No drug interventions treatment 1 withdrawn NCT03316144
Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Toripalimab for Patients With Recurrent Malignant Lymphoma No drug interventions treatment 1 completed NCT06358001
EchoTip AcuCore Post-Market Clinical Study No drug interventions Not Available Not Available recruiting NCT03062072
Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients No drug interventions Not Available Not Available unknown_status NCT00683046
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies No drug interventions treatment 2 completed NCT01324323
Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer No drug interventions other 1 completed